American Superconductor has established itself at the forefront of the global multi-billion dollar wind energy and power grid markets. After 26 years in the industry they now boast some of the most advanced systems, as well as individual components available in the space today. Spanning the entire energy value range with platform solutions tailored to the exact customer’s needs, from generation to transmission and eventual distribution, AMSC is a powerhouse provider of value-added wind and grid hardware/software.
AMSC brings a whole host of electronic controls/systems, as well as turbine designs and ancillary engineering services to some of the planet’s biggest and best manufacturers/operators via its Windtec™ Solutions division. The company can take a project from turbine conception (designs range from 1.65 MW to 10 MW) through to seamlessly hooking infrastructure up to the grid, providing entire systems or just the component the customer wants. AMSC Wind Turbine Controls and Systems help push the performance envelope to the maximum, especially in the fierce offshore arena, where the industry hungers for ever more powerful gen plants that can wring every last kilowatt-hour out of the wind’s energy. Durability, maximum uptime and availability, as well as precision quality/control are all vital factors in the equation here and smart control systems like AMSC’s wtECS™ (Electrical Control System) helps make wind more and more competitive as a source by slashing the levelized cost of electricity production (LCOE – the price, including all costs, at which electricity needs to be generated from a source to break even over the project’s lifetime).
AMSC’s Generator and Drivetrain Solutions are second-to-none in the industry today when it comes to LCOE reduction and they are available in a variety of formats. From a robust yet simple Direct Drive, to the widely used DFIG format (doubly-fed induction generators, including brushless), AMSC is a recognized leader. With solutions ranging up to full-scale conversion drivetrains, the company’s HTS Direct Drive (using power dense superconductors), and their patented SuperGEAR™ drivetrain, which gets rid of the converter and transformer altogether, AMSC has attained a considerable engineering mastery that is prized throughout the sector. Superconductors present specific, daunting manufacturing challenges and AMSC has a long track record for successfully fabricating high-temp superconductors.
The company’s Gridtec™ Solutions were in the news recently (Sept 10), with the biggest and most respected provider of turnkey high voltage solutions in South Africa, CONCO (Consolidated Power Projects), tapping the company’s D-VAR® STATCOM Renewable Interconnectivity Solution to hook up the largest wind farm in South Africa to the grid. This is a huge deal for AMSC, being the first D-VAR STATCOM (static synchronous compensator) sale into South Africa and with such a prestigious customer, it bodes well for the company, especially considering that AMSC was chosen for their proven ability to meet even the most stringent of grid code requirements. The complete compensation and voltage control capabilities of the D-VAR, which has fully dynamic reactive VAR compensation, makes the platform ideal for renewable power plants and continuous interconnectivity. AMSC currently has over 20 power grid operators worldwide using the D-VAR STATCOM solution and has orders for more than 100.
The company’s D-VAR RT is a great in-turbine retrofit that lets operators do unit-level voltage control upgrades and their Wind-RT™ Systems go even further, having been developed specifically to meet Chinese grid code specs. With sub-20 millisecond turbine isolation on power dips and immediate modulation, the Wind-RT is a simple, cost-effective low voltage ride through (LVRT) solution that helps maintain a constant voltage profile, keeps the turbine magnetized and running at a constant speed/torque, then smoothly reconnects the unit to the grid once voltage has been stabilized.
Back in 2011 the company sued then startup and customer, now Chinese wind powerhouse, Sinovel, for breaching the company’s trialware scheme on the control codes programmed into their wind turbine controller firmware and this unresolved issue is a potential major option value for the company.
By offering some of the most advanced and efficient control, grid interconnection, power capacity/reliability, and power conversion hardware on the market today, AMSC has managed to forge strong ties with key industry players. With HQ near Boston, Massachusetts, and operations in Asia, Australia, Europe and North America, AMSC is well positioned to continue dominating substantial territory in the wind and grid space as utilities and regulators continue to adapt their policies.
More info on American Superconductor Corp. is available at www.AMSC.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Monday, September 30, 2013
PITOOEY!, Inc. (PTOO) Offers Targeted Social Media Advertising Campaigns
A complete digital marketing agency, PITOOEY! specializes in social media advertising through services like Facebook, Twitter, YouTube and Instagram.
Social media enables businesses to reach a massive worldwide audience, while being highly targeted to achieve the best return on investment. According to industry experts, global social advertising revenues are projected to reach $14 billion by 2014. Smart advertisers are turning their attention to social media, and, as a result, the company reported record revenues and an ongoing expansion in its customer base.
According to PITOOEY! management, there is sizeable evidence that many business customers are aware of or have previously used social media to attract new customers. “Unfortunately, business owners have little time to dedicate to maintaining a presence on every social media platform in existence,” stated CEO, Jacob DiMartino. “PITOOEY! is here to provide businesses a focused approach to social media so that businesses can increase brand awareness, engage with consumers and drive sales.”
PITOOEY! and its subsidiaries collectively have more than 30 full-time employees dedicated to consulting and assisting businesses in delivering a cohesive and effective social media advertising campaign.
For more information, visit www.pitooeyinc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Social media enables businesses to reach a massive worldwide audience, while being highly targeted to achieve the best return on investment. According to industry experts, global social advertising revenues are projected to reach $14 billion by 2014. Smart advertisers are turning their attention to social media, and, as a result, the company reported record revenues and an ongoing expansion in its customer base.
According to PITOOEY! management, there is sizeable evidence that many business customers are aware of or have previously used social media to attract new customers. “Unfortunately, business owners have little time to dedicate to maintaining a presence on every social media platform in existence,” stated CEO, Jacob DiMartino. “PITOOEY! is here to provide businesses a focused approach to social media so that businesses can increase brand awareness, engage with consumers and drive sales.”
PITOOEY! and its subsidiaries collectively have more than 30 full-time employees dedicated to consulting and assisting businesses in delivering a cohesive and effective social media advertising campaign.
For more information, visit www.pitooeyinc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
CytRx, Inc. (CYTR) Reports New Aldoxorubicin Data Showing Significantly Better Results over Doxorubicin
Today before the opening bell, CytRx announced compelling preliminary data from its global Phase 2b soft tissue sarcoma trial indicating that patients treated with aldoxorubicin had a significantly higher Overall Response Rate (ORR) of 22% as compared to those administered the widely used chemotherapeutic agent doxorubicin with an ORR of 0%.
Additionally, Aldoxorubicin produced statistically significant improvement in survival rates in animals with a human model of glioblastoma (brain tumor), and showed an improved and narrow distribution of aldoxorubicin within the human body in a pharmacokinetics trial. Results from the glioblastoma trial and pharmacokinetics trial were discussed in poster presentations at the 2013 European Cancer Congress (ECCO/ESMO/ESTRO) being held in Amsterdam, Netherlands.
“We are compiling an ever-increasing portfolio of impressive human and pre-clinical data that aldoxorubicin could have an essential role in the treatment of patients with a wide range of cancers,” said CytRx President and CEO Steven A. Kriegsman. “This collective body of data gives us tremendous hope that we will be able to make an important difference in the lives of cancer patients worldwide. This data also supports our belief in the potential benefit of our linker technology platform to one day form the basis of a multi-billion dollar revenue oncology franchise with drugs to treat a wide range of cancers.
“Given the promising prospects for aldoxorubicin, we are aggressively moving forward with its clinical development,” he added. “We recently received acceptance from the U.S. Food and Drug Administration (FDA) for a protocol to conduct a Phase 2 clinical trial with aldoxorubicin in glioblastoma, a very difficult-to-treat and deadly cancer, and also plan to conduct a Phase 2 clinical trial in HIV-related Kaposi’s sarcoma.”
Executive Vice President and Chief Medical Officer Daniel Levitt, M.D., Ph.D., added. “The magnitude of the clinical response difference supports our belief that aldoxorubicin could fill an important medical need in patients with advanced soft tissue sarcoma. Although preliminary, we are certainly optimistic about aldoxorubicin’s prospects in soft tissue sarcoma based on the favorable results from our earlier second-line Phase 1b/2 clinical trial in patients who had failed other therapies and these preliminary overall response results as a first-line treatment announced today. The study is ongoing and many of the patients with tumor responses and stable disease are still receiving treatment.” The Company expects to report top-line data for the global Phase 2b clinical trial in December 2013.
To read the entire press release, visit http://dtg.fm/AQ9m
For more information on CytRx, visit http://cytrx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Additionally, Aldoxorubicin produced statistically significant improvement in survival rates in animals with a human model of glioblastoma (brain tumor), and showed an improved and narrow distribution of aldoxorubicin within the human body in a pharmacokinetics trial. Results from the glioblastoma trial and pharmacokinetics trial were discussed in poster presentations at the 2013 European Cancer Congress (ECCO/ESMO/ESTRO) being held in Amsterdam, Netherlands.
“We are compiling an ever-increasing portfolio of impressive human and pre-clinical data that aldoxorubicin could have an essential role in the treatment of patients with a wide range of cancers,” said CytRx President and CEO Steven A. Kriegsman. “This collective body of data gives us tremendous hope that we will be able to make an important difference in the lives of cancer patients worldwide. This data also supports our belief in the potential benefit of our linker technology platform to one day form the basis of a multi-billion dollar revenue oncology franchise with drugs to treat a wide range of cancers.
“Given the promising prospects for aldoxorubicin, we are aggressively moving forward with its clinical development,” he added. “We recently received acceptance from the U.S. Food and Drug Administration (FDA) for a protocol to conduct a Phase 2 clinical trial with aldoxorubicin in glioblastoma, a very difficult-to-treat and deadly cancer, and also plan to conduct a Phase 2 clinical trial in HIV-related Kaposi’s sarcoma.”
Executive Vice President and Chief Medical Officer Daniel Levitt, M.D., Ph.D., added. “The magnitude of the clinical response difference supports our belief that aldoxorubicin could fill an important medical need in patients with advanced soft tissue sarcoma. Although preliminary, we are certainly optimistic about aldoxorubicin’s prospects in soft tissue sarcoma based on the favorable results from our earlier second-line Phase 1b/2 clinical trial in patients who had failed other therapies and these preliminary overall response results as a first-line treatment announced today. The study is ongoing and many of the patients with tumor responses and stable disease are still receiving treatment.” The Company expects to report top-line data for the global Phase 2b clinical trial in December 2013.
To read the entire press release, visit http://dtg.fm/AQ9m
For more information on CytRx, visit http://cytrx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
EMCORE Corp. (EMKR) Receives Innovation Award for High-Efficiency Multi-Junction Solar Cells from AURP
EMCORE, a prominent provider of compound semiconductor-based components and subsystems for the fiber optics and solar power markets, received the Association of University Research Parks’ (AURP) Innovation Award at AURP’s International Conference Awards Luncheon on September 26, 2013. The award was presented to EMCORE’s President and Chief Executive Officer, Dr. Hong Q. Hou, for the company’s innovative work in the development and commercialization of high-efficiency multi-junction solar cells for space and terrestrial solar power applications.
The AURP presents Awards of Excellence each year in multiple categories, including the Innovation Award presented to EMCORE and the Outstanding Research/Science Park Award presented to Sandia Science & Technology Park in 2008.
In early 1998, EMCORE began its efforts to design and manufacture radiation-hardened, high-efficiency multi-junction solar cells for satellite and space power applications at the Sandia Science & Technology Park. Dr. Hong Hou, who transferred to EMCORE from Sandia National Laboratories, led the research and development team in the licensing of background intellectual properties associated with multi-junction solar cells from Sandia, the Air Force Research Laboratory, and the National Renewable Energy Laboratory. EMCORE then went on to establish its Photovoltaics division in Albuquerque, New Mexico centered on its 160,000 square foot state-of-the-art semiconductor wafer fabrication facility. This facility is one of the largest multi-junction solar cell manufacturing plants in the world.
EMCORE’s high-efficiency multi-junction solar cells have led the way in the transformation of the space solar power industry over the past 15 years. EMCORE’s entry into the industry has advanced solar cell efficiency from 17%, the standard for silicon-based technology prior to 1998, to 37% conversion efficiency for its latest generation Inverted Metamorphic Multi-Junction (IMM) solar cells that are currently being introduced to volume production. With the success of the commercialization of high-efficiency multi-junction solar cells for space power applications, EMCORE relocated its corporate headquarters from New Jersey to the SS&TP in Albuquerque in 2006.
“We are very pleased and honored to receive the AURP’s Innovation Award for our work in multi-junction solar cell technology development and commercialization,” said Dr. Hong Hou, President and Chief Executive Officer for EMCORE. “I would also like to thank the Sandia National Laboratories and the SS&TP for their superb resources and support of our efforts from the very beginning. And, I would especially like to thank our employees in the photovoltaics division for their dedication and innovative work all these years, paving the way for EMCORE’s success in the industry.”
“EMCORE is more than deserving of the AURP’s Innovation Award,” said Jackie Kerby Moore, Executive Director of the SS&TP. “They are creating products used in the global marketplace, and they are doing most of that right here in the Sandia Science &Technology Park.”
For further information, please visit www.emcore.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The AURP presents Awards of Excellence each year in multiple categories, including the Innovation Award presented to EMCORE and the Outstanding Research/Science Park Award presented to Sandia Science & Technology Park in 2008.
In early 1998, EMCORE began its efforts to design and manufacture radiation-hardened, high-efficiency multi-junction solar cells for satellite and space power applications at the Sandia Science & Technology Park. Dr. Hong Hou, who transferred to EMCORE from Sandia National Laboratories, led the research and development team in the licensing of background intellectual properties associated with multi-junction solar cells from Sandia, the Air Force Research Laboratory, and the National Renewable Energy Laboratory. EMCORE then went on to establish its Photovoltaics division in Albuquerque, New Mexico centered on its 160,000 square foot state-of-the-art semiconductor wafer fabrication facility. This facility is one of the largest multi-junction solar cell manufacturing plants in the world.
EMCORE’s high-efficiency multi-junction solar cells have led the way in the transformation of the space solar power industry over the past 15 years. EMCORE’s entry into the industry has advanced solar cell efficiency from 17%, the standard for silicon-based technology prior to 1998, to 37% conversion efficiency for its latest generation Inverted Metamorphic Multi-Junction (IMM) solar cells that are currently being introduced to volume production. With the success of the commercialization of high-efficiency multi-junction solar cells for space power applications, EMCORE relocated its corporate headquarters from New Jersey to the SS&TP in Albuquerque in 2006.
“We are very pleased and honored to receive the AURP’s Innovation Award for our work in multi-junction solar cell technology development and commercialization,” said Dr. Hong Hou, President and Chief Executive Officer for EMCORE. “I would also like to thank the Sandia National Laboratories and the SS&TP for their superb resources and support of our efforts from the very beginning. And, I would especially like to thank our employees in the photovoltaics division for their dedication and innovative work all these years, paving the way for EMCORE’s success in the industry.”
“EMCORE is more than deserving of the AURP’s Innovation Award,” said Jackie Kerby Moore, Executive Director of the SS&TP. “They are creating products used in the global marketplace, and they are doing most of that right here in the Sandia Science &Technology Park.”
For further information, please visit www.emcore.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Identive Group, Inc. (INVE) Announces Management Promotions and New Chairman of the Board
Deliverer of trusted access solutions, Identive Group announced the recruitment of Steven Humphreys as its new chairman of the board. The company also reported the promotion of Lawrence Midland to the position of president and Dr. Manfred Mueller to chief operating officer.
“Identive’s ability to operate as a united, focused company is strengthened with the appointments approved by our board today,” stated chief executive officer of Identive, Jason Hart. “Steve brings practical wisdom and experience to the role of chairman, gained from his successes as a technology executive and as a long-time affiliate of the company. Larry and Manfred combine excellent operational performance with strong leadership and passion. These changes continue our momentum to refocus the company, simplify our structure and leverage our strong capabilities to deliver trusted access solutions for the connected world.”
Responding to his acceptance of the position of chairman, Humphreys commented, “This is a time of major evolution for the security industry and an exciting time for Identive. The company has unique strengths and expertise to address the growing need to trust everything in the connected world — including people, buildings, information, and even assets. I look forward to working with Jason and the senior leadership team. On behalf of the board, I would like to express our appreciation to Ayman for his leadership and service.”
A director of the company since 1996, Steven Humphreys was previously an independent director and prior to that served as chairman of the board from 2000 to 2007. Additionally, from 1996 to 2000 he served in the positions of president and chief executive officer. Humphreys will succeed Ayman S. Ashour.
With over 25-years of experience, Humphreys has led numerous technology companies, including ActivCard, Kleer Corporation, and the Caere Corporation. He currently serves as the chief executive officer of Flywheel Software, Inc., a privately held location-based mobile solutions company.
Co-founder of Hirsch Electronics in 1981, Lawrence Midland led the company until its acquisition by Identive in 2009. Post-acquisition he served as executive officer and director of Identive, specifically managing the HIRSCH brand of physical access control products, systems and services, of which currently make up one-quarter of the company’s revenues. Prior to Hirsch Electronics, Midland held the position of president of several companies. His experience also includes various sales positions in investment-related firms, as well as a position with Shell Oil Company as a field engineer. He holds a BS degree in Physics from the University of Oklahoma and an MBA degree from Pepperdine University.
Dr. Manfred Mueller has been a part of Identive for over 13 years, holding a number of roles. His background includes positions in sales, marketing, and operations. He currently leads Identive’s global products business, of which approximates for half of the company’s current revenues. Previously, from 1998 to 2000 Mueller held the role of business product manager at BetaResearch GmbH, the digital TV technology development division of the Kirch Group. He earned a MS and PhD degree in Chemistry from Regensburg University in Germany and an MBA from the Heriot Watt University in Edinburgh, Scotland.
To learn more, visit www.identive-group.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“Identive’s ability to operate as a united, focused company is strengthened with the appointments approved by our board today,” stated chief executive officer of Identive, Jason Hart. “Steve brings practical wisdom and experience to the role of chairman, gained from his successes as a technology executive and as a long-time affiliate of the company. Larry and Manfred combine excellent operational performance with strong leadership and passion. These changes continue our momentum to refocus the company, simplify our structure and leverage our strong capabilities to deliver trusted access solutions for the connected world.”
Responding to his acceptance of the position of chairman, Humphreys commented, “This is a time of major evolution for the security industry and an exciting time for Identive. The company has unique strengths and expertise to address the growing need to trust everything in the connected world — including people, buildings, information, and even assets. I look forward to working with Jason and the senior leadership team. On behalf of the board, I would like to express our appreciation to Ayman for his leadership and service.”
A director of the company since 1996, Steven Humphreys was previously an independent director and prior to that served as chairman of the board from 2000 to 2007. Additionally, from 1996 to 2000 he served in the positions of president and chief executive officer. Humphreys will succeed Ayman S. Ashour.
With over 25-years of experience, Humphreys has led numerous technology companies, including ActivCard, Kleer Corporation, and the Caere Corporation. He currently serves as the chief executive officer of Flywheel Software, Inc., a privately held location-based mobile solutions company.
Co-founder of Hirsch Electronics in 1981, Lawrence Midland led the company until its acquisition by Identive in 2009. Post-acquisition he served as executive officer and director of Identive, specifically managing the HIRSCH brand of physical access control products, systems and services, of which currently make up one-quarter of the company’s revenues. Prior to Hirsch Electronics, Midland held the position of president of several companies. His experience also includes various sales positions in investment-related firms, as well as a position with Shell Oil Company as a field engineer. He holds a BS degree in Physics from the University of Oklahoma and an MBA degree from Pepperdine University.
Dr. Manfred Mueller has been a part of Identive for over 13 years, holding a number of roles. His background includes positions in sales, marketing, and operations. He currently leads Identive’s global products business, of which approximates for half of the company’s current revenues. Previously, from 1998 to 2000 Mueller held the role of business product manager at BetaResearch GmbH, the digital TV technology development division of the Kirch Group. He earned a MS and PhD degree in Chemistry from Regensburg University in Germany and an MBA from the Heriot Watt University in Edinburgh, Scotland.
To learn more, visit www.identive-group.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Ku6 Media Co., Ltd. (KUTV) Video Chart for Monday, September 30, 2013
KUTV is a low floater that is making a solid uptrend since lows in March. The pps has essentially been riding the 50-day moving average with a sharp move on Friday giving hints that the chart may be ready for the next leg up. On a pullback, look for support around $1.50 to hold.
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
ForceField Energy, Inc. (FNRG) Partners with Louisiana Nursing Home Association, Promoting Adoption of LED Lighting Solutions
ForceField Energy, a global company whose products and solutions focus on renewable energy and improved energy efficiency, has signed a consulting and sales agreement for LED lighting products with LNHA Service Corporation servicing the Louisiana Nursing Home Association’s Member (“LNHA”), a non-profit representing more than 250 nursing facilities and assisted living communities that care for approximately 30,000 elderly and disabled individuals.
Per the agreement, LNHA will provide support for the marketing and sales efforts with its existing members. The non-profit will also leverage its long-standing experience to penetrate the approximate 80,000 U.S.-based nursing homes and long-term care establishments with combined annual revenues approximating $200 billion.
“The long-term care and healthcare markets represent significant opportunities given the continued aging of the general, domestic population and the push for greater efficiency by healthcare providers,” FNRG Chairman Richard St-Julien stated in the press release. “With their more than 55 years of industry experience, we are proud to partner with a respected leader such as LNHA that clearly understands the needs of both the patients and facility of long-term care facilities. We are confident that the insight and accessibility LNHA brings to this partnership will enable us to increase awareness as to the many benefits of LED lighting and provide us with significant revenue opportunities for our products and services.”
FNRG notes that entities choose to utilize LED based largely on safety advantages the lighting systems provide. The typical nursing home has inadequate lighting, which creates a safety hazard for its residents and may have an adverse effect on mood and productivity. FNRG says leading medical studies on major depressive disorders in elderly individuals have shown that using bright light treatment may improve the patients’ mood, sleep and hormonal rhythms.
Better lighting in these environments may also encourage independence among nursing home residents while reducing the demand on the facility’s staff.
“Improving staff efficiency, lowering operating costs, and enhancing safety first provide significant value to long-term care facility operators and their residents, and second addresses the key challenges that the industry faces as a result of the increased health needs of its residents and reimbursement pressures,” stated Myron Chatelain, LNHA’s Service Corp. manager. “In the light of these challenges and through the significant benefits available with LED lighting, we are confident that by partnering with ForceField we can accelerate the adoption of LED lighting in the market.”
For more information visit www.forcefieldenergy.com, www.transpacenergy.com, or www.lightsky-led.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Per the agreement, LNHA will provide support for the marketing and sales efforts with its existing members. The non-profit will also leverage its long-standing experience to penetrate the approximate 80,000 U.S.-based nursing homes and long-term care establishments with combined annual revenues approximating $200 billion.
“The long-term care and healthcare markets represent significant opportunities given the continued aging of the general, domestic population and the push for greater efficiency by healthcare providers,” FNRG Chairman Richard St-Julien stated in the press release. “With their more than 55 years of industry experience, we are proud to partner with a respected leader such as LNHA that clearly understands the needs of both the patients and facility of long-term care facilities. We are confident that the insight and accessibility LNHA brings to this partnership will enable us to increase awareness as to the many benefits of LED lighting and provide us with significant revenue opportunities for our products and services.”
FNRG notes that entities choose to utilize LED based largely on safety advantages the lighting systems provide. The typical nursing home has inadequate lighting, which creates a safety hazard for its residents and may have an adverse effect on mood and productivity. FNRG says leading medical studies on major depressive disorders in elderly individuals have shown that using bright light treatment may improve the patients’ mood, sleep and hormonal rhythms.
Better lighting in these environments may also encourage independence among nursing home residents while reducing the demand on the facility’s staff.
“Improving staff efficiency, lowering operating costs, and enhancing safety first provide significant value to long-term care facility operators and their residents, and second addresses the key challenges that the industry faces as a result of the increased health needs of its residents and reimbursement pressures,” stated Myron Chatelain, LNHA’s Service Corp. manager. “In the light of these challenges and through the significant benefits available with LED lighting, we are confident that by partnering with ForceField we can accelerate the adoption of LED lighting in the market.”
For more information visit www.forcefieldenergy.com, www.transpacenergy.com, or www.lightsky-led.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
DreamTeamGroup (DTG) to Provide Comprehensive Social Media Coverage of LD Micro Invitational
DreamTeamGroup (DTG), a consortium of unique marketing brands that utilizes one dynamic approach to connect publicly traded companies with a variety of investors, will provide the investment community with ongoing social media coverage of the LD Micro Invitational (Best of the Best) investor conference at Luxe Sunset Bel Air, Los Angeles, October 2, 2013.
To learn more about the presenting companies, visit http://ldmicro.missionir.com/
DTG will tap into the expertise and capabilities of its extensive line of business brands to keep the investment community informed on each company that presents during the day-long conference. DTG will issue blogs, status updates and a special newsletter, providing the investment community with the most up-to-date information available.
“DreamTeamGroup has extensive resources that enable us to provide up-to-the-minute, comprehensive coverage of this year’s LD Micro Invitational,” stated Michael McCarthy, managing director of DTG. “Utilizing our unique portfolio of business brands and deep social media network, we will release updates on attending companies as they begin their presentations at the conference, and will also send a special newsletter profiling the event to our subscribers.”
To subscribe to ongoing social media updates, follow MissionIR on Facebook, Twitter, or Google+.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
To learn more about the presenting companies, visit http://ldmicro.missionir.com/
DTG will tap into the expertise and capabilities of its extensive line of business brands to keep the investment community informed on each company that presents during the day-long conference. DTG will issue blogs, status updates and a special newsletter, providing the investment community with the most up-to-date information available.
“DreamTeamGroup has extensive resources that enable us to provide up-to-the-minute, comprehensive coverage of this year’s LD Micro Invitational,” stated Michael McCarthy, managing director of DTG. “Utilizing our unique portfolio of business brands and deep social media network, we will release updates on attending companies as they begin their presentations at the conference, and will also send a special newsletter profiling the event to our subscribers.”
To subscribe to ongoing social media updates, follow MissionIR on Facebook, Twitter, or Google+.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Friday, September 27, 2013
Away from Wall Street; Noble “X” Conference Celebrates 10th Year by Taking Over Club Med
To commemorate its tenth annual Noble “X” Conference and kick-off 30 years of business, Noble Financial Capital Markets has reserved the entire 220-acre Club Med Sandpiper Bay resort near Palm Beach Florida.
From January 19-22, 2014, Noble “X” will attract 140 corporate executive teams and qualified institutional investors baited by the rustic charm and natural beauty of Club Med and the opportunity to network and relax for the ultimate Wall Street conference.
The three-day agenda includes business, networking, and social events such as formal presentations, cocktail receptions, gourmet food and beverage, and sporting options. Furthermore, Noble “X” for the first time in its 10-year history also welcomes a spouse/partner and children’s program.
Noble Financial quotes in agreement the late Apple CEO Steve Jobs, in saying “It’s ad hoc meetings of six people called by someone who thinks he has figured out the coolest new thing ever and who wants to know what other people think of his idea.”
While the presentations and scheduled meetings are the foundation of the Noble “X” Conference, the Club Med setting encourages impromptu meeting in social settings to continue dialogue and promote innovation.
For 2014, Noble Financial has added several new opportunities for executives to gain maximum exposure with investors, such as assigned seating lunches, sector-specific breakouts and sporting adventures, including golf, tennis, sailing, water skiing, and flying trapeze.
For more information, visit http://www.nobleresearch.com/TEN/MORE.htm
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
From January 19-22, 2014, Noble “X” will attract 140 corporate executive teams and qualified institutional investors baited by the rustic charm and natural beauty of Club Med and the opportunity to network and relax for the ultimate Wall Street conference.
The three-day agenda includes business, networking, and social events such as formal presentations, cocktail receptions, gourmet food and beverage, and sporting options. Furthermore, Noble “X” for the first time in its 10-year history also welcomes a spouse/partner and children’s program.
Noble Financial quotes in agreement the late Apple CEO Steve Jobs, in saying “It’s ad hoc meetings of six people called by someone who thinks he has figured out the coolest new thing ever and who wants to know what other people think of his idea.”
While the presentations and scheduled meetings are the foundation of the Noble “X” Conference, the Club Med setting encourages impromptu meeting in social settings to continue dialogue and promote innovation.
For 2014, Noble Financial has added several new opportunities for executives to gain maximum exposure with investors, such as assigned seating lunches, sector-specific breakouts and sporting adventures, including golf, tennis, sailing, water skiing, and flying trapeze.
For more information, visit http://www.nobleresearch.com/TEN/MORE.htm
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Cardium Therapeutics Inc. (CXM) Business Strategy Builds on Key Elements, Diverse Portfolio
Cardium Therapeutics is engaged in the acquisition and development of innovative products that fall within a set range of criterion, focused on products and businesses that have demonstrated their potential to address significant unmet medical needs and having a definable pathway to commercialization.
A specific business strategy serves as a catalyst for Cardium to expand its portfolio and grow market penetration.
This strategy begins with the advancement of the company’s ASPIRE Generx® clinical study for patients with advanced coronary artery disease. Generx is currently being developed for international markets as an alternative to costly and invasive cardiovascular procedures, such as coronary artery bypass surgery and angioplasty/stents.
Cardium is also working to secure commercialization partners for marketing and sales of Excellagen®, an FDA-cleared advanced wound product. Excellagen has regulatory clearance for the treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical and dermal wounds, and more.
The company’s business strategy also includes the expansion of To Go Brands, its healthy nutraceutical supplement business with more than 25 products sold online and through mass, food and drug channels at retailers such as Whole Foods, Kroger, GNC, and the Vitamin Shoppe.
By maintaining a diverse pipeline of development and potential opportunities, Cardium is able to avoid reliance on any single technology platform or product type. As further evidence of this strategy, Cardium recently launched LifeAgain Insurance Solutions, Inc., a wholly owned subsidiary focused on providing “survivable risk” term life insurance programs for cancer survivors or individuals with other with medical conditions who are currently considered uninsurable based on traditional underwriting standards.
LifeAgain has developed the BlueMetric Select™ term life insurance program specifically designed to assist life insurance companies to provide eligible men with coverage following a cancer diagnosis or completion of a prostate cancer surgery, eliminating the traditional multi-year waiting periods and additional medical re-qualifications generally required by most life insurance companies. The BlueMetric Select program was developed based on LifeAgain’s Advanced Medical Data Analytics Platform Technology (ADAPT™).
As Cardium works to execute these key elements, the company continues to keep an eye out for additional acquisitions and licenses covering product opportunities and technologies that are in line with this long-term mission.
For more information visit www.CardiumThx.com, www.ToGoBrands.com or www.LifeAgain.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
A specific business strategy serves as a catalyst for Cardium to expand its portfolio and grow market penetration.
This strategy begins with the advancement of the company’s ASPIRE Generx® clinical study for patients with advanced coronary artery disease. Generx is currently being developed for international markets as an alternative to costly and invasive cardiovascular procedures, such as coronary artery bypass surgery and angioplasty/stents.
Cardium is also working to secure commercialization partners for marketing and sales of Excellagen®, an FDA-cleared advanced wound product. Excellagen has regulatory clearance for the treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical and dermal wounds, and more.
The company’s business strategy also includes the expansion of To Go Brands, its healthy nutraceutical supplement business with more than 25 products sold online and through mass, food and drug channels at retailers such as Whole Foods, Kroger, GNC, and the Vitamin Shoppe.
By maintaining a diverse pipeline of development and potential opportunities, Cardium is able to avoid reliance on any single technology platform or product type. As further evidence of this strategy, Cardium recently launched LifeAgain Insurance Solutions, Inc., a wholly owned subsidiary focused on providing “survivable risk” term life insurance programs for cancer survivors or individuals with other with medical conditions who are currently considered uninsurable based on traditional underwriting standards.
LifeAgain has developed the BlueMetric Select™ term life insurance program specifically designed to assist life insurance companies to provide eligible men with coverage following a cancer diagnosis or completion of a prostate cancer surgery, eliminating the traditional multi-year waiting periods and additional medical re-qualifications generally required by most life insurance companies. The BlueMetric Select program was developed based on LifeAgain’s Advanced Medical Data Analytics Platform Technology (ADAPT™).
As Cardium works to execute these key elements, the company continues to keep an eye out for additional acquisitions and licenses covering product opportunities and technologies that are in line with this long-term mission.
For more information visit www.CardiumThx.com, www.ToGoBrands.com or www.LifeAgain.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Thursday, September 26, 2013
Infinity Resources Holdings Corp. (IRHC) Subsidiary Details Economic Benefits of Food Waste Recycling at Arkansas Recycling Coalition
Brian Dick, CEO of Quest Resource Management Group, an Infinity Resources Holdings Corp. company, Tuesday spoke at the Arkansas Recycling Coalition, emphasizing the economic benefits of food waste and discussing the evolution of food waste recycling in the United States.
Dick also urged coalition participants to participate in the food recycling “revolution” that he believes is spreading across the states, underscoring Quest Resource Management’s position in the industry.
Quest Resource Management is a full service environmental consulting and management company aimed at helping Fortune 500 companies with comprehensive sustainability programs, innovative recycling solutions, and proven environmental protection.
“It is an honor for Quest to be a catalyst organization and part of the changes in recycling for the state of Arkansas and to participate in this important event,” Dick stated in the press release. “We are at a tipping point in the industry when recycling food waste is not only the right environmental solution, but is becoming a better economic proposition than landfilling it.”
While it takes roughly 30 years for food waste to break down into stable compounds in an average landfill while, an efficient composter will break down the food in a matter of a few weeks. Quest works with the largest retailers to recycle more than 800 million pounds of food waste in 2012 alone, minimizing the amount of food waste that hits the nation’s landfills.
For more information, visit www.QuestRMG.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Dick also urged coalition participants to participate in the food recycling “revolution” that he believes is spreading across the states, underscoring Quest Resource Management’s position in the industry.
Quest Resource Management is a full service environmental consulting and management company aimed at helping Fortune 500 companies with comprehensive sustainability programs, innovative recycling solutions, and proven environmental protection.
“It is an honor for Quest to be a catalyst organization and part of the changes in recycling for the state of Arkansas and to participate in this important event,” Dick stated in the press release. “We are at a tipping point in the industry when recycling food waste is not only the right environmental solution, but is becoming a better economic proposition than landfilling it.”
While it takes roughly 30 years for food waste to break down into stable compounds in an average landfill while, an efficient composter will break down the food in a matter of a few weeks. Quest works with the largest retailers to recycle more than 800 million pounds of food waste in 2012 alone, minimizing the amount of food waste that hits the nation’s landfills.
For more information, visit www.QuestRMG.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Wave Systems Corp. (WAVX) Named a “Visionary” in Gartner’s 2013 Mobile Data Protection Magic Quadrant
Wave Systems, the Trusted Computing Company and foremost expert on building security capabilities directly into endpoint computing platforms themselves, announced today that Gartner Inc. named the company a visionary in its September 2013 Magic Quadrant for Mobile Data Protection (MDP), published by John Girard and Eric Ouelett. The Magic Quadrant is comprised of companies with comprehensive visions and keen ability to execute.
“To once again be recognized in Gartner’s Magic Quadrant as a visionary is a huge honor,” said Steven Sprague, CEO for Wave. “We consider Gartner’s findings as highly credible proof that Wave has been able to and will continue to lead not only in the mobile data protection space, but also in other areas as customers look to protect their sensitive data. Wave-managed hardware encryption makes users’ devices ‘safe to lose’ since network administrators can access detailed event logs to prove sensitive data was protected should a device become lost or stolen.”
Gartner tracks software security technology in the mobile data protection market that enforces privacy policies through data encryption, and the management of access to that data on the primary and secondary storage systems of end-user devices. Laptops are the predominant product in the market, but the technologies were originally developed for use in a desktop workstation area. Gartner evaluates the inclusion of compatibility features during assessments. Potential features associated with the assessment include the Trusted Platform Module, self-encrypting devices based on the Trusted Computing Group Opal standards and OS embedded encryption such as Windows BitLocker and Mac FileVault.
The primary differentiating approach used by Wave, is to build security capabilities directly into endpoint computing platforms, rather than adding layers of software for security that tends to be more vulnerable to attack. Wave’s comprehensive portfolio of trusted computing solutions for managing data protection, authentication and malware detection allow enterprises and SMBs to:
• Ensure their devices are safe to lose, by constantly protecting data with hardware-based encryption managed by Wave. Wave Cloud is the only Cloud service on the market for managing self-encrypting drives and Wave for BitLocker™ Management enables the fast deployment of BitLocker™, the native encryption feature from Microsoft.
• Safely and securely encrypt files uploaded to cloud storage services like Dropbox™ or Microsoft SkyDrive™.
• Eliminate passwords. Ensure seamless, second-factor authentication with Wave to enable virtual smartcards and to protect credentials while using Microsoft DirectAccess.
• Ensure that only known devices are allowed on known networks. Establish persistent device identity that can’t be spoofed and gain increased visibility into endpoint health before the operating system loads with Wave Endpoint Monitor.
For further information, please visit www.wave.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“To once again be recognized in Gartner’s Magic Quadrant as a visionary is a huge honor,” said Steven Sprague, CEO for Wave. “We consider Gartner’s findings as highly credible proof that Wave has been able to and will continue to lead not only in the mobile data protection space, but also in other areas as customers look to protect their sensitive data. Wave-managed hardware encryption makes users’ devices ‘safe to lose’ since network administrators can access detailed event logs to prove sensitive data was protected should a device become lost or stolen.”
Gartner tracks software security technology in the mobile data protection market that enforces privacy policies through data encryption, and the management of access to that data on the primary and secondary storage systems of end-user devices. Laptops are the predominant product in the market, but the technologies were originally developed for use in a desktop workstation area. Gartner evaluates the inclusion of compatibility features during assessments. Potential features associated with the assessment include the Trusted Platform Module, self-encrypting devices based on the Trusted Computing Group Opal standards and OS embedded encryption such as Windows BitLocker and Mac FileVault.
The primary differentiating approach used by Wave, is to build security capabilities directly into endpoint computing platforms, rather than adding layers of software for security that tends to be more vulnerable to attack. Wave’s comprehensive portfolio of trusted computing solutions for managing data protection, authentication and malware detection allow enterprises and SMBs to:
• Ensure their devices are safe to lose, by constantly protecting data with hardware-based encryption managed by Wave. Wave Cloud is the only Cloud service on the market for managing self-encrypting drives and Wave for BitLocker™ Management enables the fast deployment of BitLocker™, the native encryption feature from Microsoft.
• Safely and securely encrypt files uploaded to cloud storage services like Dropbox™ or Microsoft SkyDrive™.
• Eliminate passwords. Ensure seamless, second-factor authentication with Wave to enable virtual smartcards and to protect credentials while using Microsoft DirectAccess.
• Ensure that only known devices are allowed on known networks. Establish persistent device identity that can’t be spoofed and gain increased visibility into endpoint health before the operating system loads with Wave Endpoint Monitor.
For further information, please visit www.wave.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Calpian, Inc. (CLPI) Targets Multiple Markets and Revenue Sources
In the U.S., Calpian, among other things, is a leader in a portion of the electronic payments industry known as merchant acquiring. Specifically, Calpian purchases recurring monthly income streams derived from credit card processing fees paid by U.S. retail merchants. Small and medium size businesses typically buy credit card processing services from ISOs (Independent Sales Organizations) that in turn work with one or more credit card processors. Calpian buys residual portfolios from ISOs that originated the contracts with merchants. Calpian also acquires ISOs who maintain sales forces to engage merchants directly and arrange credit and debit card processing services from processors.
In addition, Calpian has a growing financial position in India’s Money on Mobile service (MoM), a mobile payment processing service in India. It is believed to be the largest store network for mobile phone based transactions providing mobile top-up and DTH (Direct To Home) recharge services in India. MoM has identified two potential revenue streams. Its business model generates revenue from phone and TV bulk buying discounts (a proven current source of revenue), and consumer fees (3% per transaction) applied to transactions not involving purchase of a service.
First is via business-to-business (B2B) activity, consisting of the reselling of prepaid phone and prepaid TV time to retailers who then resell that time to consumers. This activity is currently operational and generating revenues.
The second way MoM plans to generate revenue is to empower consumers to use their cell phones to make payments directly to vendors and other consumers. Such direct person-to-person transfer payments are known as domestic remittances. According to BankNetIndia, the total transaction value of domestic remittance in India stood at $13.0 billion in 2010 with 80% of domestic remittance directed towards rural areas. This overall market is expected to reach about $20.3 billion by 2014, growing at a compound annual growth rate of 12%.
For additional information, visit www.Calpian.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
In addition, Calpian has a growing financial position in India’s Money on Mobile service (MoM), a mobile payment processing service in India. It is believed to be the largest store network for mobile phone based transactions providing mobile top-up and DTH (Direct To Home) recharge services in India. MoM has identified two potential revenue streams. Its business model generates revenue from phone and TV bulk buying discounts (a proven current source of revenue), and consumer fees (3% per transaction) applied to transactions not involving purchase of a service.
First is via business-to-business (B2B) activity, consisting of the reselling of prepaid phone and prepaid TV time to retailers who then resell that time to consumers. This activity is currently operational and generating revenues.
The second way MoM plans to generate revenue is to empower consumers to use their cell phones to make payments directly to vendors and other consumers. Such direct person-to-person transfer payments are known as domestic remittances. According to BankNetIndia, the total transaction value of domestic remittance in India stood at $13.0 billion in 2010 with 80% of domestic remittance directed towards rural areas. This overall market is expected to reach about $20.3 billion by 2014, growing at a compound annual growth rate of 12%.
For additional information, visit www.Calpian.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Wheeler Real Estate Investment Trust (WHLR) Expands Tulsa Market Presence with Acquisition of Jenks Reasor’s
Wheeler Real Estate Investment Trust announced it has acquired an 81,000-square-foot freestanding retail property in Jenks, Okla., for approximately $11.4 million, or $140.74 per square foot. The property, Jenks Reasor’s, was acquired through a sale-leaseback purchase contract with Reasor’s Foods.
Jenks Reasor’s, built in 2011, is located in one of the fastest growing communities in Oklahoma, located just 30 miles from Tulsa. The property is leased by employee-owned regional grocery chain Reasor’s Foods, one of the largest grocers in Oklahoma with 17 locations throughout the state. The property is secured by a 20-year, single-net lease that will expire in 2033 with four five-year renewal options.
This purchase brings Wheeler’s property count to 15 in seven states across the Mid-Atlantic, Southeast, and Midwest. A company engaged in owning, acquiring, financing, developing, renovating, leasing, and managing income-producing assets, such as community centers, neighborhood centers, strip centers, and freestanding retail properties, Wheeler believes the acquisition of Jenks Reasor’s fits with its strategy of acquiring retail-focused properties with stable tenants in a community-driven, tertiary market. This acquisition expands Wheeler’s presence in the growing Tulsa market and, the company believes, will help provide a strong return on investment.
For more information, visit www.whlr.us
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Jenks Reasor’s, built in 2011, is located in one of the fastest growing communities in Oklahoma, located just 30 miles from Tulsa. The property is leased by employee-owned regional grocery chain Reasor’s Foods, one of the largest grocers in Oklahoma with 17 locations throughout the state. The property is secured by a 20-year, single-net lease that will expire in 2033 with four five-year renewal options.
This purchase brings Wheeler’s property count to 15 in seven states across the Mid-Atlantic, Southeast, and Midwest. A company engaged in owning, acquiring, financing, developing, renovating, leasing, and managing income-producing assets, such as community centers, neighborhood centers, strip centers, and freestanding retail properties, Wheeler believes the acquisition of Jenks Reasor’s fits with its strategy of acquiring retail-focused properties with stable tenants in a community-driven, tertiary market. This acquisition expands Wheeler’s presence in the growing Tulsa market and, the company believes, will help provide a strong return on investment.
For more information, visit www.whlr.us
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
PITOOEY!, Inc. (PTOO) Announces Rapid Customer Base Growth
PITOOEY!, a complete digital marketing agency, today announced the ongoing, substantial expansion of its customer base.
Choice One Mobile, Inc., a wholly owned subsidiary of the company, has added more than 350 unique customers for the quarter ending June 30, 2013. Most of these customers are enrolled in either a monthly recurring payment plan or a prepaid plan for service over a specific number of months. As indicated by the significant increase in revenue and gross profit reported earlier this month, Choice One Mobile is now one of the key growth drivers of PITOOEY!.
“We are particularly proud of our Choice One Mobile sales force and experienced social media consultants. Our team attracts and enlists customers by customizing specific programs and services to meet their varying requirements,” stated CEO, Jacob DiMartino. “Importantly, the relationship with our customers does not end with securing their account. An ongoing relationship is established and reinforced through continual individual monitoring and adjustment of the account.”
The global digital marketing industry is expected to reach over $160 billion by 2016, according to eMarketer. As a complete digital marketing agency, PITOOEY! is uniquely positioned to capitalize with an array of products and services to enhance communication between businesses and their target audiences. The company provides a variety of social media and mobile marketing services to small-sized and medium-sized businesses via its wholly owned subsidiaries: PITOOEY! Mobile, Inc. and Choice One Mobile, Inc.
For more information, visit www.PITOOEYInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Wednesday, September 25, 2013
CytRx Corp. (CYTR) – Cancer Killing Promise
Even though enormous strides have been made in the treatment of cancers in recent history, nearly 1.7 million new cases of cancer will be diagnosed in the U.S this year and close to 600 thousand will die from the disease. Cancer is an insidious group of diseases characterized by uncontrolled growth and spread of abnormal cells.
Cancer can be caused by internal factors like genetic mutations or external factors, such as lifestyle choices or exposure to toxins. Sometimes these factors act together or in sequence to trigger the development of cancer. If the spread of abnormal cells isn’t con-trolled, it usually results in death. Generally accepted cancer treatments include surgery, radiation, and chemotherapy.
One common chemotherapeutic treatment for multiple cancers with proven efficacy is doxorubicin. Doxorubicin is administered as a single agent or in combination with other chemotherapy agents for greater effect in various treatment regimens. However, serious life-threatening heart damage can occur when using doxorubicin. In trying to save a life, the patient can be at risk of dying from the treatment.
CytRx Corporation (CYTR), a R&D biopharmaceutical company, may have the solution to this paradox and other challenges in cancer treatments. CYTR holds the exclusive worldwide rights to aldoxorubicin, and the company is initiating a Phase 3 pivotal trial. Aldoxorubicin has a novel design containing a linker technology engineered to release drugs near tumors and concentrate more of the drug directly to the tumor.
Aldoxorubicin has shown to be superior to doxorubicin in seven different tumor types of cancer including ovarian, lung, breast and pancreatic cancer, as well as several other cancers. This is the first drug candidate CYTR is developing based on their novel technology. Their linker technology has the proven ability to allow attachment of multiple pharmacologic agents and is designed to provide both greater anti-cancer activity and to reduce toxicity to the patient.
Dramatic results in Phase 1 clinical trials lend great promise to the potential efficacy of aldoxorubicin. In the trials, the drug was administered at up to six times the standard dosage of doxorubicin, with no increase in observed side effects. There were no observed cardiac toxicities and no drug-related patient deaths.
Aldoxorubicin has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with soft tissue sarcomas and pancreatic cancer. CYTR also has rights to two additional drug candidates, tamibarotene, and bafetinib.
The promise of initial studies suggests that more cancer killing drugs may be delivered where they’re needed most while patients experience fewer side effects with aldoxorubicin. If this promise proves up in Phase 3 trials, it should turn CYTR into a formidable cancer killer.
For additional information about Cytrx Corporation, aldoxorubicin, and CYTR’s drug pipeline, please visit www.cytrx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Cancer can be caused by internal factors like genetic mutations or external factors, such as lifestyle choices or exposure to toxins. Sometimes these factors act together or in sequence to trigger the development of cancer. If the spread of abnormal cells isn’t con-trolled, it usually results in death. Generally accepted cancer treatments include surgery, radiation, and chemotherapy.
One common chemotherapeutic treatment for multiple cancers with proven efficacy is doxorubicin. Doxorubicin is administered as a single agent or in combination with other chemotherapy agents for greater effect in various treatment regimens. However, serious life-threatening heart damage can occur when using doxorubicin. In trying to save a life, the patient can be at risk of dying from the treatment.
CytRx Corporation (CYTR), a R&D biopharmaceutical company, may have the solution to this paradox and other challenges in cancer treatments. CYTR holds the exclusive worldwide rights to aldoxorubicin, and the company is initiating a Phase 3 pivotal trial. Aldoxorubicin has a novel design containing a linker technology engineered to release drugs near tumors and concentrate more of the drug directly to the tumor.
Aldoxorubicin has shown to be superior to doxorubicin in seven different tumor types of cancer including ovarian, lung, breast and pancreatic cancer, as well as several other cancers. This is the first drug candidate CYTR is developing based on their novel technology. Their linker technology has the proven ability to allow attachment of multiple pharmacologic agents and is designed to provide both greater anti-cancer activity and to reduce toxicity to the patient.
Dramatic results in Phase 1 clinical trials lend great promise to the potential efficacy of aldoxorubicin. In the trials, the drug was administered at up to six times the standard dosage of doxorubicin, with no increase in observed side effects. There were no observed cardiac toxicities and no drug-related patient deaths.
Aldoxorubicin has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with soft tissue sarcomas and pancreatic cancer. CYTR also has rights to two additional drug candidates, tamibarotene, and bafetinib.
The promise of initial studies suggests that more cancer killing drugs may be delivered where they’re needed most while patients experience fewer side effects with aldoxorubicin. If this promise proves up in Phase 3 trials, it should turn CYTR into a formidable cancer killer.
For additional information about Cytrx Corporation, aldoxorubicin, and CYTR’s drug pipeline, please visit www.cytrx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
NTS, Inc. (NTS) Connects First Fiber Customer in Ponchatoula, Louisiana
Yesterday, NTS announced that it has connected its first fiber customer in Ponchatoula, Louisiana. The company has had a presence in Louisiana since April 2013, when it began connecting customers throughout the state. The Louisiana network expansion is being funded by a portion of approximately $100 million in federal stimulus funding.
When completed, NTS’ fiber network in Louisiana is expected to include the Hammond, Ponchatoula, Natalbany, Tickfaw, Independence, and Amite. In addition, a wireless service extension overlay will also bring advanced broadband services to towns in the St. Helena, Washington, and Tangipahoa Parishes.
This wave of NTS’ build out, which originally began in Texas, is expected to add about 11,500 fiber passings to the company’s network. This will bring the company’s total FTTP passings to approximately 53,000.
Guy Nissenson, Chairman, NTS’s President and CEO, commented, “We are pleased to have begun adding customers in our newest market, Ponchatoula, Louisiana. We’ve seen strong adoption rates for our high speed triple play offering in Hammond, Louisiana, and we look forward to bringing advanced broadband to more customers in Ponchatoula during the coming weeks. We continue to make solid progress building out the rest of our markets in southeastern Louisiana.”
For more information on NTS and its expanding network, please visit www.ntscom.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
When completed, NTS’ fiber network in Louisiana is expected to include the Hammond, Ponchatoula, Natalbany, Tickfaw, Independence, and Amite. In addition, a wireless service extension overlay will also bring advanced broadband services to towns in the St. Helena, Washington, and Tangipahoa Parishes.
This wave of NTS’ build out, which originally began in Texas, is expected to add about 11,500 fiber passings to the company’s network. This will bring the company’s total FTTP passings to approximately 53,000.
Guy Nissenson, Chairman, NTS’s President and CEO, commented, “We are pleased to have begun adding customers in our newest market, Ponchatoula, Louisiana. We’ve seen strong adoption rates for our high speed triple play offering in Hammond, Louisiana, and we look forward to bringing advanced broadband to more customers in Ponchatoula during the coming weeks. We continue to make solid progress building out the rest of our markets in southeastern Louisiana.”
For more information on NTS and its expanding network, please visit www.ntscom.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Novavax, Inc. (NVAX) Prepares to Initiate Seasonal and Pandemic Influenza Trials with BARDA
Clinical-stage vaccine company Novavax announced that details are being finalized regarding costs and timelines for its next round of clinical studies with the U.S. Department of Health and Human Services, Biomedical Advanced Research, and Development Authority (BARDA), after successful completion of process improvement studies.
The company is getting ready to move forward with these next clinical trials for its quadrivalent seasonal influenza vaccine candidate and its pandemic influenza vaccine candidate, both of which are under U.S. INDs. The pandemic study will include use of Matrix-M, Novavax’s proprietary saponin-based adjuvant.
The clinical trials Novavax has planned for 2014 are key steps in completing the company’s goal to move these two vaccine candidates through to licensure. In consideration of the shift of the world’s disease focus from the H5N1 avian influenza strain to the H7N9 avian influenza strain, the company has expanded its pandemic program to include H7N9. The company is particularly pleased regarding BARDA’s interest in the development of both its pandemic vaccine candidates with the Matrix-M adjuvant and its seasonal vaccine program.
Novavax received a contract from BARDA in February 2011 that was valued at up to $179 million. The contract was for the advanced development of recombinant influenza vaccine products and manufacturing capabilities for pandemic preparedness. Throughout the three-year base period of the contract, which was valued at $97 million, the company has been developing and testing its novel recombinant virus-like particle (VLP) influenza vaccines to address BARDA’s commitment to advancing recombinant-based technology as part of pandemic preparedness. It is expected that the contract will be extended for an additional 24 months, following satisfaction of established milestones, upon execution by BARDA of an Option One period valued at $79 million in added funding. Milestones under the Option One period would be focused on completing the pathway to product licensures from the FDA, including support for manufacturing scale-up. An additional contract option exists for vaccine production ($3 million).
For more information, visit the Novavax Web site at www.novavax.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The company is getting ready to move forward with these next clinical trials for its quadrivalent seasonal influenza vaccine candidate and its pandemic influenza vaccine candidate, both of which are under U.S. INDs. The pandemic study will include use of Matrix-M, Novavax’s proprietary saponin-based adjuvant.
The clinical trials Novavax has planned for 2014 are key steps in completing the company’s goal to move these two vaccine candidates through to licensure. In consideration of the shift of the world’s disease focus from the H5N1 avian influenza strain to the H7N9 avian influenza strain, the company has expanded its pandemic program to include H7N9. The company is particularly pleased regarding BARDA’s interest in the development of both its pandemic vaccine candidates with the Matrix-M adjuvant and its seasonal vaccine program.
Novavax received a contract from BARDA in February 2011 that was valued at up to $179 million. The contract was for the advanced development of recombinant influenza vaccine products and manufacturing capabilities for pandemic preparedness. Throughout the three-year base period of the contract, which was valued at $97 million, the company has been developing and testing its novel recombinant virus-like particle (VLP) influenza vaccines to address BARDA’s commitment to advancing recombinant-based technology as part of pandemic preparedness. It is expected that the contract will be extended for an additional 24 months, following satisfaction of established milestones, upon execution by BARDA of an Option One period valued at $79 million in added funding. Milestones under the Option One period would be focused on completing the pathway to product licensures from the FDA, including support for manufacturing scale-up. An additional contract option exists for vaccine production ($3 million).
For more information, visit the Novavax Web site at www.novavax.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Nanosphere, Inc. (NSPH) Video Chart for Wednesday, September 25, 2013
NSPH is making a move while holding a bottom support around $1.75. The chart is showing a shift happening in trend and momentum, which should have technical traders looking for a possibly slow and steady climb similar to what happened earlier this year off the support point.
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
ForceField Energy, Inc. (FNRG) Poised for Power in Renewable Energy Sector
Global renewable energy and energy efficiency-focused company ForceField Energy is poised to become a power player in the multibillion-dollar renewable energy market.
Based in the United States, ForceField currently operates in three of the biggest and most rapidly growing areas of the worldwide renewable energy sector: industrial waste heat recovery and conversion, commercial LED lighting products, and solar cell feedstock production. The company owns 51% of the U.S.-based TransPacific Energy, Inc., which is a renewable energy provider utilizing “waste heat” from manufacturing and a variety of other sources to provide clean electricity.
ForceField recently entered into a distribution agreement with a leading Chinese LED manufacturer to serve as its exclusive North American distributor of LED commercial lighting and fixtures. In China, ForceField also serves as a significant producer of trichlorosilane (TCS), which is a chemical chiefly used in producing polysilicon, an essential raw material needed for the production of solar cells for PV panels that convert sunlight into electricity.
ForceField is positioned to leverage the widespread deployment of clean, renewable solar energy, which is one of the fastest growing trends and markets in the world today. As part of its strategy to obtain market share leadership in this area, the company is engaged in acquiring, developing, and operating a portfolio of high-quality TCS production facilities and distribution rights, taking into consideration such key characteristics as strategic location, scalability, and potential for production expansion.
For more information about the company, visit www.ForceFieldEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Based in the United States, ForceField currently operates in three of the biggest and most rapidly growing areas of the worldwide renewable energy sector: industrial waste heat recovery and conversion, commercial LED lighting products, and solar cell feedstock production. The company owns 51% of the U.S.-based TransPacific Energy, Inc., which is a renewable energy provider utilizing “waste heat” from manufacturing and a variety of other sources to provide clean electricity.
ForceField recently entered into a distribution agreement with a leading Chinese LED manufacturer to serve as its exclusive North American distributor of LED commercial lighting and fixtures. In China, ForceField also serves as a significant producer of trichlorosilane (TCS), which is a chemical chiefly used in producing polysilicon, an essential raw material needed for the production of solar cells for PV panels that convert sunlight into electricity.
ForceField is positioned to leverage the widespread deployment of clean, renewable solar energy, which is one of the fastest growing trends and markets in the world today. As part of its strategy to obtain market share leadership in this area, the company is engaged in acquiring, developing, and operating a portfolio of high-quality TCS production facilities and distribution rights, taking into consideration such key characteristics as strategic location, scalability, and potential for production expansion.
For more information about the company, visit www.ForceFieldEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Galena Biopharma, Inc. (GALE) Reports Closing of Over-Allotment Option, Resulting in Total Gross Proceeds of $37.6M
Galena Biopharma, a biopharmaceutical company developing and commercializing targeted oncology treatments to advance cancer care, has closed the exercise of the previously announced underwriters’ option to purchase an additional 2,625,000 shares of the company’s common stock.
As part of the firm commitment underwritten offering that was closed September 18, 2013, Galena granted the underwriters a 30-day option to purchase up to 2,625,000 shares of common stock and/or warrants to purchase up to 918,750 shares of common stock.
The underwriters have exercised their over-allotment option in full, contributing additional gross proceeds to Galena of approximately $5.2 million. The net proceeds to Galena, including from the exercise in full of the over-allotment options, are expected to be approximately $37.6 million.
Galena said it intends to use the net proceeds of the offering to commercialize its first commercial product, Abstral® (fentanyl) Sublingual Tablets, and its ongoing phase 3 NeuVax™ (nelipepimut S) PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment) clinical trial, other clinical trials of its product candidates, and for general corporate purposes.
For more information, visit www.galenabiopharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
As part of the firm commitment underwritten offering that was closed September 18, 2013, Galena granted the underwriters a 30-day option to purchase up to 2,625,000 shares of common stock and/or warrants to purchase up to 918,750 shares of common stock.
The underwriters have exercised their over-allotment option in full, contributing additional gross proceeds to Galena of approximately $5.2 million. The net proceeds to Galena, including from the exercise in full of the over-allotment options, are expected to be approximately $37.6 million.
Galena said it intends to use the net proceeds of the offering to commercialize its first commercial product, Abstral® (fentanyl) Sublingual Tablets, and its ongoing phase 3 NeuVax™ (nelipepimut S) PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment) clinical trial, other clinical trials of its product candidates, and for general corporate purposes.
For more information, visit www.galenabiopharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Jameson Stanford Resources Corp. (JMSN) Initiates Diamond Core Drilling Program
Jameson Stanford Resources, a metals and minerals exploration, development, and production company, announced that it has been managing an extensive third party engineering Diamond Core Drilling Program within the Wild Bill area at the northern end of its Star Mountain Mining District, Chopar Mine located in Beaver County, Utah.
“Jameson Stanford Resources’ current exploration program and technical reports associated with aerial and ground magnetometer surveys, modeling, geologic ground reconnaissance, geo mapping, surface sampling, and extensive reverse circulation drilling, warranted graduation to diamond core drilling to further delineate the sizable mineralized porphyry discovered at the Wild Bill area of the property,” stated Michael Stanford, President of Jameson Stanford Resources Corp.
The company completed its reverse circulation drilling program of the area earlier this year when 14 of 15 drill holes intersected near surface mineralization continuing to a depth of 500 feet (152.4 meters), then commenced diamond core drilling in August. The diamond core drilling will be complete this November and will culminate with N.I. 43-101 and SEC Industry Guide 7 reporting on the area. The Wild Bill area represents approximately one-fifth of the 4,998 acres comprising the Chopar Mine.
Diamond core drilling is used in the mining and metallurgy industry to probe the contents of known mineralized deposits for their potential by drilling with a hollow diamond impregnated, or surfaced bit, and a core barrel to obtain a rock core. Geologists then can analyze the core visually with the aid of optics, by chemical assay, and conduct petrologic, structural, and mineralogical studies of the rock.
For more information, visit www.JamesonStanford.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“Jameson Stanford Resources’ current exploration program and technical reports associated with aerial and ground magnetometer surveys, modeling, geologic ground reconnaissance, geo mapping, surface sampling, and extensive reverse circulation drilling, warranted graduation to diamond core drilling to further delineate the sizable mineralized porphyry discovered at the Wild Bill area of the property,” stated Michael Stanford, President of Jameson Stanford Resources Corp.
The company completed its reverse circulation drilling program of the area earlier this year when 14 of 15 drill holes intersected near surface mineralization continuing to a depth of 500 feet (152.4 meters), then commenced diamond core drilling in August. The diamond core drilling will be complete this November and will culminate with N.I. 43-101 and SEC Industry Guide 7 reporting on the area. The Wild Bill area represents approximately one-fifth of the 4,998 acres comprising the Chopar Mine.
Diamond core drilling is used in the mining and metallurgy industry to probe the contents of known mineralized deposits for their potential by drilling with a hollow diamond impregnated, or surfaced bit, and a core barrel to obtain a rock core. Geologists then can analyze the core visually with the aid of optics, by chemical assay, and conduct petrologic, structural, and mineralogical studies of the rock.
For more information, visit www.JamesonStanford.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
VistaGen Therapeutics, Inc. (VSTA) Human Clinical Trials in a Test Tube™ Aims to Revive Failed Small Drug Molecule Candidates
VistaGen has developed a stem cell technology platform based on the controlled transformation of human pluripotent stem cells into mature human cells, which can then be used to create bioassay systems to provide clinically relevant predictions on the toxicity and metabolism issues of promising new drug candidates before they are ever tested in human subjects.
The company sees a huge disadvantage to the pharmaceutical industry in that conventional animal and in vitro cell culture testing only approximates human biology, generating risk for failed drug candidates and wasted resources.
VistaGen leverages its Human Clinical Trials in a Test Tube™ platform to mitigate such losses and to revive once-promising small drug molecule candidates that failed in the development process due to heart or liver toxicity or metabolism issues.
Human Clinical Trials in a Test Tube™ is based on a combination of proprietary and exclusively licensed stem cell technologies, some of which were developed over the past two decades by co-founders and renowned Canadian stem cell scientist Dr. Gordon Keller and company president and Chief Scientific Officer Dr. Ralph Snodgrass.
Backed with such expertise and technology, the company only focuses on discontinued drug candidates with positive preclinical efficacy data to identify and develop new, safe drug rescue variants in a faster and less expensive manner than drug candidates discovered and developed using animal studies, and in vitro cell culture testing systems.
For more information, visit www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The company sees a huge disadvantage to the pharmaceutical industry in that conventional animal and in vitro cell culture testing only approximates human biology, generating risk for failed drug candidates and wasted resources.
VistaGen leverages its Human Clinical Trials in a Test Tube™ platform to mitigate such losses and to revive once-promising small drug molecule candidates that failed in the development process due to heart or liver toxicity or metabolism issues.
Human Clinical Trials in a Test Tube™ is based on a combination of proprietary and exclusively licensed stem cell technologies, some of which were developed over the past two decades by co-founders and renowned Canadian stem cell scientist Dr. Gordon Keller and company president and Chief Scientific Officer Dr. Ralph Snodgrass.
Backed with such expertise and technology, the company only focuses on discontinued drug candidates with positive preclinical efficacy data to identify and develop new, safe drug rescue variants in a faster and less expensive manner than drug candidates discovered and developed using animal studies, and in vitro cell culture testing systems.
For more information, visit www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Tuesday, September 24, 2013
Chanticleer Holdings, Inc. (HOTR) Carves Out Leading Franchise Presence Domestically and Abroad
Buffalo wings. Orange shorts. Cold Beer. Hooters® has unarguably become one of the nation’s most well-known brands in the casual dining segment of the restaurant industry. Not limited to the male demographic, the restaurant chain feeds men, women, and children of all ages. What’s not as well-known is that Hooters® has a growing presence in international markets as well here in the United States.
Chanticleer Holdings is the powerhouse behind the brand’s foreign exposure, focused on expanding the Hooters™ presence in the international markets in key territories with favorable demographics and room for growth.
The company operates Hooters® locations in South Africa, Europe and Australia, with plans to open shop in Brazil in the near future. Chanticleer most recently signed a binding letter of intent to acquire an existing Hooters® location in Nottingham, England, in a deal expected to close on or before October 31, 2013.
This acquisition will bring the total number of restaurants Chanticleer operations to seven, and as its franchise portfolio grows, so do the revenues.
For the three months ended March 31, 2013, Chanticleer grew total revenues to $1.6 million from revenue of $1.4 million for the same quarter the year prior. For the nine months ended September 30, 2102, the company grew revenue to $4.9 million as compared to $468,417 in the same period of 2011.
Chanticleer also has a minority interest in the privately held parent company of the Hooters® brand, Hooters of America (HOA), for which Chanticleer CEO Michael Pruitt sits on the board of directors. Because HOA is a private entity, buying shares in Chanticleer is the best way for the average person to invest in the Hooters brand.
For more information, visit www.ChanticleerHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Chanticleer Holdings is the powerhouse behind the brand’s foreign exposure, focused on expanding the Hooters™ presence in the international markets in key territories with favorable demographics and room for growth.
The company operates Hooters® locations in South Africa, Europe and Australia, with plans to open shop in Brazil in the near future. Chanticleer most recently signed a binding letter of intent to acquire an existing Hooters® location in Nottingham, England, in a deal expected to close on or before October 31, 2013.
This acquisition will bring the total number of restaurants Chanticleer operations to seven, and as its franchise portfolio grows, so do the revenues.
For the three months ended March 31, 2013, Chanticleer grew total revenues to $1.6 million from revenue of $1.4 million for the same quarter the year prior. For the nine months ended September 30, 2102, the company grew revenue to $4.9 million as compared to $468,417 in the same period of 2011.
Chanticleer also has a minority interest in the privately held parent company of the Hooters® brand, Hooters of America (HOA), for which Chanticleer CEO Michael Pruitt sits on the board of directors. Because HOA is a private entity, buying shares in Chanticleer is the best way for the average person to invest in the Hooters brand.
For more information, visit www.ChanticleerHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
NuPathe, Inc. (PATH) Begins Dosing Adolescent Migraine Sufferers in ZECUITY Clinical Study
Specialty pharmaceutical company NuPathe has begun dosing patients for NP101-015, a Phase 1 study of ZECUITY (sumatriptan iontophoretic transdermal system) in adolescents with a history of migraine attacks.
An open label, single-dose study, NP101-015 will assess the safety, pharmacokinetics, and tolerability of ZECUITY in adolescent migraine patients. The drug was approved by the FDA in January for the acute treatment of migraine with or without aura in adults. ZECUITY is the first and only FDA-approved patch for treating migraine. The study is part of NuPathe’s post-marketing requirements.
Currently, oral tablets are the only approved administration route for acute treatment of migraine attacks in adolescents. An analysis of the largest survey of migraine sufferers, the landmark American Migraine Prevalence and Prevention Study (AMPP), showed that 5% of boys and 7.7% of girls ages 12 to 19 meet the ICHD-2 criteria for migraine. Adolescents suffer the same basic migraine symptoms as adults, such as headache pain, migraine-related nausea, photophobia, and phonophobia. A retrospective review of Glaxo Wellcome (now GlaxoSmithKlien) adolescent clinical trials database (N = 1,952) shows that 53% of adolescent patients experienced nausea.
The NP101-015 trial will enroll up to 36 adolescent patients, ages 12 to 17, who have a history of acute migraine attacks but are otherwise healthy. There will be a similar number of patients between the ages of 12 and 14 and the ages of 15 to 17, with distribution of both sexes in each age bracket. The study’s primary objectives are to determine the safety and tolerability of a single dose of ZECUITY in adolescent subjects with a history of acute migraine and to determine the pharmacokinetics of sumatriptan in adolescent subjects when delivered by ZECUITY’s transdermal administration route. The study’s results are expected in July 2014.
For more information, visit www.zecuity.com and www.nupathe.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
An open label, single-dose study, NP101-015 will assess the safety, pharmacokinetics, and tolerability of ZECUITY in adolescent migraine patients. The drug was approved by the FDA in January for the acute treatment of migraine with or without aura in adults. ZECUITY is the first and only FDA-approved patch for treating migraine. The study is part of NuPathe’s post-marketing requirements.
Currently, oral tablets are the only approved administration route for acute treatment of migraine attacks in adolescents. An analysis of the largest survey of migraine sufferers, the landmark American Migraine Prevalence and Prevention Study (AMPP), showed that 5% of boys and 7.7% of girls ages 12 to 19 meet the ICHD-2 criteria for migraine. Adolescents suffer the same basic migraine symptoms as adults, such as headache pain, migraine-related nausea, photophobia, and phonophobia. A retrospective review of Glaxo Wellcome (now GlaxoSmithKlien) adolescent clinical trials database (N = 1,952) shows that 53% of adolescent patients experienced nausea.
The NP101-015 trial will enroll up to 36 adolescent patients, ages 12 to 17, who have a history of acute migraine attacks but are otherwise healthy. There will be a similar number of patients between the ages of 12 and 14 and the ages of 15 to 17, with distribution of both sexes in each age bracket. The study’s primary objectives are to determine the safety and tolerability of a single dose of ZECUITY in adolescent subjects with a history of acute migraine and to determine the pharmacokinetics of sumatriptan in adolescent subjects when delivered by ZECUITY’s transdermal administration route. The study’s results are expected in July 2014.
For more information, visit www.zecuity.com and www.nupathe.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
DreamTeamGroup (DTG) to Provide Comprehensive Social Media Coverage of Aegis Healthcare Conference 2013
DreamTeamGroup (DTG), a consortium of unique marketing brands that utilizes one dynamic approach to connect publicly traded companies with a variety of investors, will provide the investment community with ongoing social media coverage of the Aegis Healthcare Conference at The Wynn, Las Vegas, September 25-28, 2013.
To learn more about the presenting companies, visit http://www.aegis.missionir.com/
Throughout the three-day conference, DTG will tap into the expertise and capabilities of its extensive line of business brands to keep the investment community informed via blogs, status updates and a special newsletter.
“DreamTeamGroup has a unique portfolio of business brands, each one backed by a far-reaching social media network that will serve as a powerful communication vehicle throughout this year’s Aegis Healthcare Conference,” stated Michael McCarthy, managing director of DTG. “To ensure comprehensive coverage of the conference we will release updates on attending companies as they begin their presentations, and will send a special newsletter profiling the event to our subscribers.”
To subscribe to ongoing social media updates, follow MissionIR on Facebook, Twitter, or Google+.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
To learn more about the presenting companies, visit http://www.aegis.missionir.com/
Throughout the three-day conference, DTG will tap into the expertise and capabilities of its extensive line of business brands to keep the investment community informed via blogs, status updates and a special newsletter.
“DreamTeamGroup has a unique portfolio of business brands, each one backed by a far-reaching social media network that will serve as a powerful communication vehicle throughout this year’s Aegis Healthcare Conference,” stated Michael McCarthy, managing director of DTG. “To ensure comprehensive coverage of the conference we will release updates on attending companies as they begin their presentations, and will send a special newsletter profiling the event to our subscribers.”
To subscribe to ongoing social media updates, follow MissionIR on Facebook, Twitter, or Google+.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
PITOOEY! Inc. (PTOO) Recognizes the Original Promise of Digital Communications
Internet communication and marketing, and its merger with mobile device technology, has been both a blessing and a curse to the consumer. It allows for an information flow unparalleled in human experience, where information of all types has the potential of being available to anyone at any time, no matter where they are.
In terms of marketing, it allows every type of product and service to be offered quickly and cheaply, directly to the individual. Digital electronics has made it as easy to send a million messages as to send one, and has provided an unlimited number of options for determining when and how a marketing message is displayed. The problem of course is that the world-changing flexibility and power of such technology has become as abusive as beneficial, often alienating the very consumers it is meant to attract.
Imagine walking down the street and being relentlessly followed by someone trying to get you into their Chinese restaurant. The fact that you hate Chinese food is of no concern to them; they just keep following and trying to persuade you with their latest sales. Somewhere along the line their digital algorithms have decided that you are a target. Now multiply that irritation by potentially every vendor in town. The result is clearly not fulfilling the promise of digital communication sought by consumers and vendors.
PITOOEY! Inc. has developed a new approach to market communication, together with the technology to support it, an approach designed to better serve both vendors and consumers. Through its subsidiary, PITOOEY! Mobile and the company’s flagship mobile app, “PITOOEY!”, the company has embraced the concept of consumer-centric marketing.
Upon login on the PITOOEY! app, users create a personalized profile of their favorite businesses via the easy-to-use search and subscribe feature, whether a retail business, restaurant, hotel, etc., all with a simple click of a button. It’s easy and fun to build a customized list of businesses and instantly connect to them. Users will then only receive deals and notifications from the companies on their lists; no unwanted messages, ever. From the vendor’s side, the system offers businesses small or large the ability to flip the traditional communications landscape by connecting them with people who have already displayed interest in their business.
For more information, visit www.PITOOEY.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
In terms of marketing, it allows every type of product and service to be offered quickly and cheaply, directly to the individual. Digital electronics has made it as easy to send a million messages as to send one, and has provided an unlimited number of options for determining when and how a marketing message is displayed. The problem of course is that the world-changing flexibility and power of such technology has become as abusive as beneficial, often alienating the very consumers it is meant to attract.
Imagine walking down the street and being relentlessly followed by someone trying to get you into their Chinese restaurant. The fact that you hate Chinese food is of no concern to them; they just keep following and trying to persuade you with their latest sales. Somewhere along the line their digital algorithms have decided that you are a target. Now multiply that irritation by potentially every vendor in town. The result is clearly not fulfilling the promise of digital communication sought by consumers and vendors.
PITOOEY! Inc. has developed a new approach to market communication, together with the technology to support it, an approach designed to better serve both vendors and consumers. Through its subsidiary, PITOOEY! Mobile and the company’s flagship mobile app, “PITOOEY!”, the company has embraced the concept of consumer-centric marketing.
Upon login on the PITOOEY! app, users create a personalized profile of their favorite businesses via the easy-to-use search and subscribe feature, whether a retail business, restaurant, hotel, etc., all with a simple click of a button. It’s easy and fun to build a customized list of businesses and instantly connect to them. Users will then only receive deals and notifications from the companies on their lists; no unwanted messages, ever. From the vendor’s side, the system offers businesses small or large the ability to flip the traditional communications landscape by connecting them with people who have already displayed interest in their business.
For more information, visit www.PITOOEY.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Monday, September 23, 2013
On Track Innovations Ltd. (OTIV) Receives Orders from Petroleum Partner for Commercial Quantities of EasyFuel Plus Product
On Track Innovations (“OTI”), a supplier of near field communication and cashless payment solutions worldwide, announced that Tokheim has placed orders for commercial quantities of OTI’s EasyFuel Plus solution. Tokheim is one of the world’s premier manufacturers and service providers of fuel dispensing and automation equipment.
Since the partnership was formed in September of 2010, Tokheim’s point of sale controllers have featured integration of EasyFuel Plus at both commercial fleet and retail petroleum stations across 12 countries. The implementation for a prominent petroleum retailer has already begun in four European markets.
EasyFuel Plus equipment has been supplied to over 250 Tokheim locations, which includes more than 1,000 nozzles and 7,500 vehicles to date. OTI’s value-added reseller for EasyFuel Plus, OTI Africa, is responsible for managing the integration with Tokheim’s point of sale controllers and the application business rules.
SmartFuel decreases fraud and boosts fuel management capabilities while playing its vital role in Tokheim’s commercial fleet offering.
“The continued adoption of our EasyFuel Plus technology by Tokheim reflects the increasing strength of our strategic partnership and Tokheim’s ability to successfully demonstrate how our technology secures and simplifies the payment processes,” commented Ofer Tziperman, OTI’s CEO. “The demand for EasyFuel Plus has gained momentum as customers globally recognize the benefits of automated vehicle identification and the need for quality data. We therefore envisage that our petroleum products will serve as one of the main growth engines for our business.”
Kurt Dillen, general manager of Tokheim’s Systems & Electronics Business Unit, commented: “It has been an interesting journey to develop and package with OTI the perfect vehicle identification solution for our fuel retail and fleet customers. As a result of a great effort and a high level of cooperation between the engineering teams of OTI and Tokheim, we can state today that we have the best-in-class solution in the world to simplify payment, increase throughput and improve the overall refueling experience. Tokheim is not only offering this product solution, but with our local service organizations we are also able to provide after sales service. I am convinced that Tokheim will deliver this easy-to-use solution to many more markets and customers in the following years.”
For further information, please visit www.tokheim.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Since the partnership was formed in September of 2010, Tokheim’s point of sale controllers have featured integration of EasyFuel Plus at both commercial fleet and retail petroleum stations across 12 countries. The implementation for a prominent petroleum retailer has already begun in four European markets.
EasyFuel Plus equipment has been supplied to over 250 Tokheim locations, which includes more than 1,000 nozzles and 7,500 vehicles to date. OTI’s value-added reseller for EasyFuel Plus, OTI Africa, is responsible for managing the integration with Tokheim’s point of sale controllers and the application business rules.
SmartFuel decreases fraud and boosts fuel management capabilities while playing its vital role in Tokheim’s commercial fleet offering.
“The continued adoption of our EasyFuel Plus technology by Tokheim reflects the increasing strength of our strategic partnership and Tokheim’s ability to successfully demonstrate how our technology secures and simplifies the payment processes,” commented Ofer Tziperman, OTI’s CEO. “The demand for EasyFuel Plus has gained momentum as customers globally recognize the benefits of automated vehicle identification and the need for quality data. We therefore envisage that our petroleum products will serve as one of the main growth engines for our business.”
Kurt Dillen, general manager of Tokheim’s Systems & Electronics Business Unit, commented: “It has been an interesting journey to develop and package with OTI the perfect vehicle identification solution for our fuel retail and fleet customers. As a result of a great effort and a high level of cooperation between the engineering teams of OTI and Tokheim, we can state today that we have the best-in-class solution in the world to simplify payment, increase throughput and improve the overall refueling experience. Tokheim is not only offering this product solution, but with our local service organizations we are also able to provide after sales service. I am convinced that Tokheim will deliver this easy-to-use solution to many more markets and customers in the following years.”
For further information, please visit www.tokheim.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Thursday, September 19, 2013
CytRx Corp. (CYTR) Featured as High-Potential, Low Risk Play in Seeking Alpha Opine
CytRx, a biopharmaceutical research and development company specializing in oncology, is currently developing three programs for multiple cancer indications. The company’s lead candidate is aldoxorubicin, a modified version of the widely used chemotherapy agent doxorubicin.
The company’s progress recently got the attention of Seeking Alpha contributor, Equity Options Guru, who considers CYTR a forgotten but “major opportunity” player in the healthcare space.
“With tens of billions of dollars being poured into cancer research each year, the companies involved in this space are attempting to create the next breakthrough therapy that can help alleviate suffering for many patients around the world. One such company, CytRx Corporation (CYTR), appears poised for greatness but it hasn’t participated in the cancer rally over the past few years which begs the question, why not?,” he questions in the article titled “CytRx Corporation Remains an Undiscovered Opportunity in the Caner Space.”
In demonstrating the valuation, opportunity, and advances of comparable players in the oncology market, the article lays out four main reasons for a bullish take on the company:
Hedge fund Baker Brothers’ stake of 1 million shares of CYTR stock
CYTR’s advantages over other biotech platforms
Simple and Effective Mechanism
Minimizing Toxicity
Applicable to Several Forms of Cancer
Intellectual Property Strength
Market potential and favorable clinical performance of aldoxorubicin
Solid cash position with low burn rate
Equity Options Guru sees CYTR as a low-risk option, noting that the company’s diversity in potential treatments dilutes the risk of complete share price collapse in the event that one clinical trial should fail.
“CytRx appears to have the makings of a company poised for a significant run over the next couple of years. The risks appear to be minimal while the potential appears to be enormous particularly if aldoxorubicin works for glioblastoma,” the author writes. “Over the next couple of years, CytRx will be making a series of significant announcements including results from several trials. Investors should strongly consider keeping this company on their radar and perhaps even making an investment.”
To read the Seeking Alpha article in its entirety visit: http://seekingalpha.com/article/1700372
For more information visit www.CytRx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The company’s progress recently got the attention of Seeking Alpha contributor, Equity Options Guru, who considers CYTR a forgotten but “major opportunity” player in the healthcare space.
“With tens of billions of dollars being poured into cancer research each year, the companies involved in this space are attempting to create the next breakthrough therapy that can help alleviate suffering for many patients around the world. One such company, CytRx Corporation (CYTR), appears poised for greatness but it hasn’t participated in the cancer rally over the past few years which begs the question, why not?,” he questions in the article titled “CytRx Corporation Remains an Undiscovered Opportunity in the Caner Space.”
In demonstrating the valuation, opportunity, and advances of comparable players in the oncology market, the article lays out four main reasons for a bullish take on the company:
Hedge fund Baker Brothers’ stake of 1 million shares of CYTR stock
CYTR’s advantages over other biotech platforms
Simple and Effective Mechanism
Minimizing Toxicity
Applicable to Several Forms of Cancer
Intellectual Property Strength
Market potential and favorable clinical performance of aldoxorubicin
Solid cash position with low burn rate
Equity Options Guru sees CYTR as a low-risk option, noting that the company’s diversity in potential treatments dilutes the risk of complete share price collapse in the event that one clinical trial should fail.
“CytRx appears to have the makings of a company poised for a significant run over the next couple of years. The risks appear to be minimal while the potential appears to be enormous particularly if aldoxorubicin works for glioblastoma,” the author writes. “Over the next couple of years, CytRx will be making a series of significant announcements including results from several trials. Investors should strongly consider keeping this company on their radar and perhaps even making an investment.”
To read the Seeking Alpha article in its entirety visit: http://seekingalpha.com/article/1700372
For more information visit www.CytRx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
American Apparel (APP) to Sponsor Female-Centric Art Exhibition on September 20-23rd
Global fashion chain American Apparel announced yesterday that it’s sponsoring a female-centric art exhibition, dubbed “Gynolandscape,” which will take place at Four81 in SoHo, NYC, from September 20-23rd. Petra Collins, photographer and longtime American Apparel employee, is curating the show.
Collins, a Toronto-born artist, has worked with Vogue Italia, Purple, Vice, and Rookie, and is still a contributing photographer for American Apparel. She was hired by the company as a retail employee at only 15 years old before pursuing her career in photography.
The Toronto-born artist attributes her interest in American Apparel to the realism of the company’s earliest ads. “I was 14. You could see the model had armpit hair and her body wasn’t retouched,” Collins said. “That spoke so loudly to me – it was totally different from anything I’d ever seen before.”
Iris Alonzo, American Apparel’s creative director, commented, “We are excited to be supporting this exhibit curated by a rising artist. Petra’s talent was evident since the first days that she worked in our retail stores and it has been a pleasure to see her creativity thrive. It’s an honor to support her and these strong female artists and their work.”
The exhibit features approximately 40 female artists, including Sandy Kim, Jeanette Hayes, Jaimie Warren, Olivia Bee, Kristie Muller, and Karley Sciortino, in addition to artists from the Ardorous. The show, a celebration of female equality, will feature archival photography from American Apparel photographers Kyung Chung, Iris Alonzo, and Marsha Brady. These women, as well as the thousands of female employees in retail, planning, leadership, and technical roles, have been the driving force behind American Apparel’s imagery and operations since its inception.
For more information, visit www.americanapparel.net
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Collins, a Toronto-born artist, has worked with Vogue Italia, Purple, Vice, and Rookie, and is still a contributing photographer for American Apparel. She was hired by the company as a retail employee at only 15 years old before pursuing her career in photography.
The Toronto-born artist attributes her interest in American Apparel to the realism of the company’s earliest ads. “I was 14. You could see the model had armpit hair and her body wasn’t retouched,” Collins said. “That spoke so loudly to me – it was totally different from anything I’d ever seen before.”
Iris Alonzo, American Apparel’s creative director, commented, “We are excited to be supporting this exhibit curated by a rising artist. Petra’s talent was evident since the first days that she worked in our retail stores and it has been a pleasure to see her creativity thrive. It’s an honor to support her and these strong female artists and their work.”
The exhibit features approximately 40 female artists, including Sandy Kim, Jeanette Hayes, Jaimie Warren, Olivia Bee, Kristie Muller, and Karley Sciortino, in addition to artists from the Ardorous. The show, a celebration of female equality, will feature archival photography from American Apparel photographers Kyung Chung, Iris Alonzo, and Marsha Brady. These women, as well as the thousands of female employees in retail, planning, leadership, and technical roles, have been the driving force behind American Apparel’s imagery and operations since its inception.
For more information, visit www.americanapparel.net
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Glowpoint, Inc. (GLOW) Announces Release of Reservation-Less Videoconferencing Service
Leading cloud-based video collaboration, network, and support services provider Glowpoint has announced the release of Glowpoint Now, a reservation-less videoconferencing service that allows easy video collaboration for anyone, anywhere, on any device.
Organizations have increasingly varied needs when it comes to video collaboration. Some require video that surpasses the four walls of a company to include a mobile workforce as well as business partners. Others are in need of high-touch concierge services to accommodate board meetings and executive interviews. Still others need on-demand videoconferencing or an offsite video meeting room. Most are in need of a combination of services, as well as support and assistance to help them more effectually collaborate with colleagues, business partners, and customers.
“Many reservation-less videoconferencing startups lead you to believe that as video becomes more pervasive, support requirements diminish or go away. The exact opposite is true,” said Glowpoint Chairman and CEO Peter Holst. “The demand for secure, enterprise-grade video collaboration is expanding globally, and, with that expansion, the need to provide business-class services and support is increasing. Glowpoint Now, in combination with our other video collaboration and support services, meets our customers’ needs today and into the future.”
Glowpoint Now enables customers to start or join a meeting from a Web browser, schedule meetings and include participants more engagingly, using Outlook or inviting them “on the fly.” Service highlights of Glowpoint Now include: a low cost burden, as utilization of The Glowpoint Cloud eliminates the need for infrastructure or IT training; integration into customers’ unified communications strategies, including seamless compatibility with Microsoft Lync and Cisco Jabber; comprehensive management and reporting, including performance and trend reports and the capability for authorized users to easily add or remove participants, set or change security levels and monitor usages; and partner friendliness, enabling partner branding and coverage by Glowpoint’s business-class support services.
For more details about Glowpoint Now, visit www.glowpoint.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Organizations have increasingly varied needs when it comes to video collaboration. Some require video that surpasses the four walls of a company to include a mobile workforce as well as business partners. Others are in need of high-touch concierge services to accommodate board meetings and executive interviews. Still others need on-demand videoconferencing or an offsite video meeting room. Most are in need of a combination of services, as well as support and assistance to help them more effectually collaborate with colleagues, business partners, and customers.
“Many reservation-less videoconferencing startups lead you to believe that as video becomes more pervasive, support requirements diminish or go away. The exact opposite is true,” said Glowpoint Chairman and CEO Peter Holst. “The demand for secure, enterprise-grade video collaboration is expanding globally, and, with that expansion, the need to provide business-class services and support is increasing. Glowpoint Now, in combination with our other video collaboration and support services, meets our customers’ needs today and into the future.”
Glowpoint Now enables customers to start or join a meeting from a Web browser, schedule meetings and include participants more engagingly, using Outlook or inviting them “on the fly.” Service highlights of Glowpoint Now include: a low cost burden, as utilization of The Glowpoint Cloud eliminates the need for infrastructure or IT training; integration into customers’ unified communications strategies, including seamless compatibility with Microsoft Lync and Cisco Jabber; comprehensive management and reporting, including performance and trend reports and the capability for authorized users to easily add or remove participants, set or change security levels and monitor usages; and partner friendliness, enabling partner branding and coverage by Glowpoint’s business-class support services.
For more details about Glowpoint Now, visit www.glowpoint.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Cardium Therapeutics, Inc. (CXM) Subsidiary Shows Support for Life Insurance Awareness Month
LifeAgain Insurance Solutions, a wholly owned subsidiary of Cardium Therapeutics, today announced its support of Life Insurance Awareness Month. Taking place during September, this campaign is sponsored by the Life and Health Insurance Foundation for Education (LIFE). LIFE’s aim is to help people take personal financial responsibility through the ownership of life insurance and other related insurance, including disability and long-term care insurance, to financially protect their loved ones.
Although life insurance rates for the traditional insurable population are at record lows, the percentage of U.S. households with coverage has steadily declined over the past 25 years—from 62 percent in 1985 to an all-time 50-year low of 44 percent in 2010. However, for cancer patients who really do “need life insurance,” their hands often are tied. Life insurance typically only becomes an option after five years of being cancer free. Even then, it can be an uphill battle depending on the type, stage, grade of the cancer, and the treatment plan.
In response, LifeAgain recently launched its BlueMetric™ Select term life insurance program for men with active localized prostate cancer. This program was developed based on LifeAgain’s Advanced Medical Data Analytics Platform Technology (ADAPT™). Prostate cancer is one of the most prevalent forms of cancer in the United States. Currently, men with elevated prostate-specific antigen (PSA) scores and active localized prostate cancer usually are considered uninsurable based on traditional underwriting standards. LifeAgain’s BlueMetric Select program was specifically designed to assist life insurance companies to provide eligible men with term life insurance coverage following a cancer diagnosis or upon the completion of a prostate cancer surgery, without the traditional multi-year waiting periods and additional medical re-qualifications generally required by most life insurance companies.
Additional information about the BlueMetric Select Program is available at www.lifeagain.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Although life insurance rates for the traditional insurable population are at record lows, the percentage of U.S. households with coverage has steadily declined over the past 25 years—from 62 percent in 1985 to an all-time 50-year low of 44 percent in 2010. However, for cancer patients who really do “need life insurance,” their hands often are tied. Life insurance typically only becomes an option after five years of being cancer free. Even then, it can be an uphill battle depending on the type, stage, grade of the cancer, and the treatment plan.
In response, LifeAgain recently launched its BlueMetric™ Select term life insurance program for men with active localized prostate cancer. This program was developed based on LifeAgain’s Advanced Medical Data Analytics Platform Technology (ADAPT™). Prostate cancer is one of the most prevalent forms of cancer in the United States. Currently, men with elevated prostate-specific antigen (PSA) scores and active localized prostate cancer usually are considered uninsurable based on traditional underwriting standards. LifeAgain’s BlueMetric Select program was specifically designed to assist life insurance companies to provide eligible men with term life insurance coverage following a cancer diagnosis or upon the completion of a prostate cancer surgery, without the traditional multi-year waiting periods and additional medical re-qualifications generally required by most life insurance companies.
Additional information about the BlueMetric Select Program is available at www.lifeagain.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Calpian, Inc. (CLPI) CEO Harold Montgomery Details Money-on-Mobile Technology and Position in Huge Indian Market at CorporateProfile.com
Harold Montgomery, CEO of mobile payment solutions provider Calpian, is a recognized industry leader who has testified to the U.S. Congress and Federal Reserve Bank on payments-related issues and regularly appears in numerous industry publications.
At the recent 15th annual Rodman & Renshaw Conference in New York City, Montgomery discussed the services platform of its Money-on-Mobile Indian subsidiary, the Indian leader in pre-paid mobile payment solutions.
“Money-on-Mobile has grown tremendously in its short three-year life span,” Montgomery states in the company’s corporate profile. “We’ve attracted over 67 million unique users since April 1 of last year.”
He further explains that MOM has more than 157,800 retail locations nationwide, 8.5 million regular users in a month, and processes 12.5 million transactions each month.
To watch the Montgomery explain Calpian’s technology and position in the Indian market visit: http://www.corporateprofile.com/2013/09/18/interview-w-calpian-inc-clpi-ceo-harold-montgomery/.
Calpian has corporate offices in Dallas, Texas, and operating centers in Georgia and New York.
For more information, visit www.calpian.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
At the recent 15th annual Rodman & Renshaw Conference in New York City, Montgomery discussed the services platform of its Money-on-Mobile Indian subsidiary, the Indian leader in pre-paid mobile payment solutions.
“Money-on-Mobile has grown tremendously in its short three-year life span,” Montgomery states in the company’s corporate profile. “We’ve attracted over 67 million unique users since April 1 of last year.”
He further explains that MOM has more than 157,800 retail locations nationwide, 8.5 million regular users in a month, and processes 12.5 million transactions each month.
To watch the Montgomery explain Calpian’s technology and position in the Indian market visit: http://www.corporateprofile.com/2013/09/18/interview-w-calpian-inc-clpi-ceo-harold-montgomery/.
Calpian has corporate offices in Dallas, Texas, and operating centers in Georgia and New York.
For more information, visit www.calpian.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Wednesday, September 18, 2013
ZipRealty, Inc. (ZIPR) Releases List of Top 10 Booming Real Estate Markets with Highest-Ranking Public Schools
Leading online technology-powered real estate brokerage firm and real estate marketing solutions provider ZipRealty, Inc. has announced its list of the top 10 booming real estate markets with the best public schools in the U.S. As of mid-August 2013, these metro areas are leaders in median home price growth. The listed public schools in these areas were chosen because of their high “School Score,” which is ZipRealty’s exclusive proprietary measure of each school district’s performance on a scale from one to 10, 10 being the highest.
As home values and school scores are inseparably linked, ZipRealty gives users the most complete picture of a home’s value by providing a School Score, which is calculated based on test score data and student/teacher ratios.
ZipRealty.com allows homebuyers focused on moving into a particular school district to start their home search by entering the school district’s name in the search bar. Users can additionally find a School Score on every ZipRealty.com listing.
Topping ZipRealty’s list at No.1 is Sacramento, Calif., where median home prices have increased 40% year-over-year to $245,000. The Rocklin Unified School District in Sacramento received a School Score of 8.5. Also ranking high on the list at No. 2 is the San Francisco Bay Area, where median home prices have increased by 36% year-over-year and Piedmont Unified School District received a School Score of 9.5. Las Vegas ranked third on the list, followed by Los Angeles at No. 4, Orlando at No. 5, Phoenix at No. 6, San Diego at No. 7, California’s Orange County at No. 8, Chicago at No. 9 and Portland, Ore., at No. 10. A full a copy of the report, including specific metro-level housing metrics, can be obtained by e-mailing Stacey Corso at scorso@ziprealty.com.
For more information about ZipRealty, visit www.ziprealty.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
As home values and school scores are inseparably linked, ZipRealty gives users the most complete picture of a home’s value by providing a School Score, which is calculated based on test score data and student/teacher ratios.
ZipRealty.com allows homebuyers focused on moving into a particular school district to start their home search by entering the school district’s name in the search bar. Users can additionally find a School Score on every ZipRealty.com listing.
Topping ZipRealty’s list at No.1 is Sacramento, Calif., where median home prices have increased 40% year-over-year to $245,000. The Rocklin Unified School District in Sacramento received a School Score of 8.5. Also ranking high on the list at No. 2 is the San Francisco Bay Area, where median home prices have increased by 36% year-over-year and Piedmont Unified School District received a School Score of 9.5. Las Vegas ranked third on the list, followed by Los Angeles at No. 4, Orlando at No. 5, Phoenix at No. 6, San Diego at No. 7, California’s Orange County at No. 8, Chicago at No. 9 and Portland, Ore., at No. 10. A full a copy of the report, including specific metro-level housing metrics, can be obtained by e-mailing Stacey Corso at scorso@ziprealty.com.
For more information about ZipRealty, visit www.ziprealty.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
ForceField Energy Inc. (FNRG) Chief Executive Offer Joins MissionIR in Exclusive Interview
MissionIR today announces that its interview with David Natan, the Chief Executive Officer of ForceField Energy, is now available online. The audio interview can be heard at http://fnrg.missionir.com/interview.html.
In the interview, Natan provides an overview of the rapidly growing energy sectors being targeted by the Company’s multifaceted business model. He discusses ForceField Energy’s proprietary waste heat conversion technology, which profitably converts waste heat generated from industry processes and other sources into clean energy, as well as its exclusive license to distribute high-performance LED lighting products in North America, Mexico, Latin America and the Caribbean.
ForceField Energy is operated by a highly experienced management team with numerous years of business development and public company experience in a high profile environment. Natan describes the backgrounds and qualifications of several key members of ForceField Energy management, as well as details his own experience as Chief Financial Officer of four listed U.S. public companies.
In his comprehensive review of the company, Natan also touches on ForceField Energy’s overall growth strategy and the recent significant progress made by the Company on several fronts.
For more information, visit www.FNRG.MissionIR.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
In the interview, Natan provides an overview of the rapidly growing energy sectors being targeted by the Company’s multifaceted business model. He discusses ForceField Energy’s proprietary waste heat conversion technology, which profitably converts waste heat generated from industry processes and other sources into clean energy, as well as its exclusive license to distribute high-performance LED lighting products in North America, Mexico, Latin America and the Caribbean.
ForceField Energy is operated by a highly experienced management team with numerous years of business development and public company experience in a high profile environment. Natan describes the backgrounds and qualifications of several key members of ForceField Energy management, as well as details his own experience as Chief Financial Officer of four listed U.S. public companies.
In his comprehensive review of the company, Natan also touches on ForceField Energy’s overall growth strategy and the recent significant progress made by the Company on several fronts.
For more information, visit www.FNRG.MissionIR.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
iPass, Inc. (IPAS) Report Details Hotel Wi-Fi as the Second Most Important Amenity for Business Travelers
Leading online technology-powered real estate brokerage firm and real estate marketing solutions provider ZipRealty, Inc. has announced its list of the top 10 booming real estate markets with the best public schools in the U.S. As of mid-August 2013, these metro areas are leaders in median home price growth. The listed public schools in these areas were chosen because of their high “School Score,” which is ZipRealty’s exclusive proprietary measure of each school district’s performance on a scale from one to 10, 10 being the highest.
As home values and school scores are inseparably linked, ZipRealty gives users the most complete picture of a home’s value by providing a School Score, which is calculated based on test score data and student/teacher ratios.
ZipRealty.com allows homebuyers focused on moving into a particular school district to start their home search by entering the school district’s name in the search bar. Users can additionally find a School Score on every ZipRealty.com listing.
Topping ZipRealty’s list at No.1 is Sacramento, Calif., where median home prices have increased 40% year-over-year to $245,000. The Rocklin Unified School District in Sacramento received a School Score of 8.5. Also ranking high on the list at No. 2 is the San Francisco Bay Area, where median home prices have increased by 36% year-over-year and Piedmont Unified School District received a School Score of 9.5. Las Vegas ranked third on the list, followed by Los Angeles at No. 4, Orlando at No. 5, Phoenix at No. 6, San Diego at No. 7, California’s Orange County at No. 8, Chicago at No. 9 and Portland, Ore., at No. 10. A full a copy of the report, including specific metro-level housing metrics, can be obtained by e-mailing Stacey Corso at scorso@ziprealty.com.
For more information about ZipRealty, visit www.ziprealty.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
As home values and school scores are inseparably linked, ZipRealty gives users the most complete picture of a home’s value by providing a School Score, which is calculated based on test score data and student/teacher ratios.
ZipRealty.com allows homebuyers focused on moving into a particular school district to start their home search by entering the school district’s name in the search bar. Users can additionally find a School Score on every ZipRealty.com listing.
Topping ZipRealty’s list at No.1 is Sacramento, Calif., where median home prices have increased 40% year-over-year to $245,000. The Rocklin Unified School District in Sacramento received a School Score of 8.5. Also ranking high on the list at No. 2 is the San Francisco Bay Area, where median home prices have increased by 36% year-over-year and Piedmont Unified School District received a School Score of 9.5. Las Vegas ranked third on the list, followed by Los Angeles at No. 4, Orlando at No. 5, Phoenix at No. 6, San Diego at No. 7, California’s Orange County at No. 8, Chicago at No. 9 and Portland, Ore., at No. 10. A full a copy of the report, including specific metro-level housing metrics, can be obtained by e-mailing Stacey Corso at scorso@ziprealty.com.
For more information about ZipRealty, visit www.ziprealty.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
VistaGen Therapeutics, Inc. (VSTA) Has Head Start in Race to Develop New Drug Rescue Variants
VistaGen is a biotech small-cap applying its stem cell technology to revive once-promising drug candidates that were shelved due to heart and liver safety concerns. Pharmaceutical companies spend millions of dollars and decades of time researching new drug candidates to advance them into clinical development. If the drug candidate fails to achieve a favorable safety profile in late-stage preclinical development, further development often grinds to a halt, and with it, the potential therapeutic and commercial benefits.
Approximately one-third of all potential new drug candidates fail in preclinical or clinical trials due to safety concerns, leaving a wake of lame-duck therapeutic possibilities that could save lives and advance science in leaps and bounds.
This is where VistaGen takes the baton. The company believes that valuable accuracy and application are lost in testing animal subjects, which only approximate human biology and can lead to unexpected safety issues. Conversely, VistaGen aims to provide predictive toxicology and metabolism screening systems that more closely approximate human biology in early development phases.
Leveraging its Human Clinical Trials in a Test Tube™ platform, VistaGen is positioned to have a “head start” in the identification and development of new, proprietary Drug Rescue Variants in a more rapid and less expensive manner than drug candidates discovered and developed using conventional and in vitro cell culture testing.
The technology allows for the controlled differentiation of human pluripotent stem cells into mature, functional human cells, which may allow researchers to identify human toxicity or metabolism issues early in the drug development process, saving money and freeing up resources to focus on drug candidates with the highest probability of success.
VistaGen believes that this capability has the potential to significantly reduce drug development costs, while producing effective and safer drugs.
For more information, visit www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Approximately one-third of all potential new drug candidates fail in preclinical or clinical trials due to safety concerns, leaving a wake of lame-duck therapeutic possibilities that could save lives and advance science in leaps and bounds.
This is where VistaGen takes the baton. The company believes that valuable accuracy and application are lost in testing animal subjects, which only approximate human biology and can lead to unexpected safety issues. Conversely, VistaGen aims to provide predictive toxicology and metabolism screening systems that more closely approximate human biology in early development phases.
Leveraging its Human Clinical Trials in a Test Tube™ platform, VistaGen is positioned to have a “head start” in the identification and development of new, proprietary Drug Rescue Variants in a more rapid and less expensive manner than drug candidates discovered and developed using conventional and in vitro cell culture testing.
The technology allows for the controlled differentiation of human pluripotent stem cells into mature, functional human cells, which may allow researchers to identify human toxicity or metabolism issues early in the drug development process, saving money and freeing up resources to focus on drug candidates with the highest probability of success.
VistaGen believes that this capability has the potential to significantly reduce drug development costs, while producing effective and safer drugs.
For more information, visit www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Tuesday, September 17, 2013
Pitooey!, Inc. (PTOO) Push and Pull Profit Potential
Communication has changed radically in the last few decades. New mediums have displaced traditional formats and most everything has moved to digital. Like everything else, advertising and marketing have shifted into the digital era to take advantage of the new mediums which are now mobile and direct to the consumer. However, consumers are often bombarded and overwhelmed with all the mobile offers pushed to them. Recently, a technological shift occurred in the digital advertising and marketing arena. This change not only benefits businesses but empowers consumers.
A new player has entered the digital marketing arena with solutions that could have a dramatic impact on communications between business and the consumer. PITOOEY! provides social and mobile marketing products and services for business and consumers through its wholly owned subsidiaries: Choice One Mobile and PITOOEY! Mobile.
Choice One Mobile is a digital and social media and marketing company that deliver customizable digital marketing solutions for business. Choice One Mobile’s services help establish a credible Web presence and leverage a business’s existing consumer knowledge to maximize profitability.
PITOOEY! Mobile is a consumer centered proprietary mobile app. This new mobile application is a profile based search engine within a mobile app. It lets users personalize profiles of their favorite businesses and enables them to receive info, offers, and updates on their own terms.
The PITOOEY! app is a preference based, searchable ad network. Using the proprietary PITOOEY! platform, businesses are able to upload messages and offers into a database, which consumers “pull” based on their pre-chosen preferences. This gives businesses a unique marketing interface while delivering consumers content, deals, and location-based information.
A mobile application designed not to “integrate” (hide) advertising within a consumer product, PITOOEY! is built from the ground up to manage an infinite number of robust, dynamic, and individualized advertising messages – i.e. marketing that the consumer actually wants. The consumer controls the timing and selection of advertising, while simultaneously the business controls the ad content. The result is a clear value proposition for both the consumer and business, and pushes PITOOEY! to a leading position in today’s digital advertising world.
For more information, visit www.PitooeyInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
A new player has entered the digital marketing arena with solutions that could have a dramatic impact on communications between business and the consumer. PITOOEY! provides social and mobile marketing products and services for business and consumers through its wholly owned subsidiaries: Choice One Mobile and PITOOEY! Mobile.
Choice One Mobile is a digital and social media and marketing company that deliver customizable digital marketing solutions for business. Choice One Mobile’s services help establish a credible Web presence and leverage a business’s existing consumer knowledge to maximize profitability.
PITOOEY! Mobile is a consumer centered proprietary mobile app. This new mobile application is a profile based search engine within a mobile app. It lets users personalize profiles of their favorite businesses and enables them to receive info, offers, and updates on their own terms.
The PITOOEY! app is a preference based, searchable ad network. Using the proprietary PITOOEY! platform, businesses are able to upload messages and offers into a database, which consumers “pull” based on their pre-chosen preferences. This gives businesses a unique marketing interface while delivering consumers content, deals, and location-based information.
A mobile application designed not to “integrate” (hide) advertising within a consumer product, PITOOEY! is built from the ground up to manage an infinite number of robust, dynamic, and individualized advertising messages – i.e. marketing that the consumer actually wants. The consumer controls the timing and selection of advertising, while simultaneously the business controls the ad content. The result is a clear value proposition for both the consumer and business, and pushes PITOOEY! to a leading position in today’s digital advertising world.
For more information, visit www.PitooeyInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)